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Abstract
Research undertaken in the last three decades has consistently reported that the length
of time spent in inpatient and outpatient alcohol and other drug (AOD) treatment
programs predicts treatment success (De Leon, Melnick, Kressel, & Jainchill, 1994;
Hubbard, Craddock, & Anderson, 2003; Simpson, Joe, Fletcher, Hubbard, & Anglin,
1999). However, treatment attrition rates are high and present a major problem for
improving treatment outcomes. Various factors that have been reportedly associated
with increased AOD treatment attrition rates include being female, younger clients,
clients using methamphetamines, and clients with elevated psychopathology scores.
The aim of this thesis is to improve understanding of various factors reported in the
research literature to influence AOD treatment retention, including client
psychopathology, age, gender and primary drug of abuse.
The research was conducted in two phases. Phase one involved an analysis of
archival data of clients admitted to a single Australian therapeutic community (TC)
program over a 6-year period (2000-2005).The second stage involved a focus group
comprised of nine Australian and New Zealand therapeutic community managers and
senior clinicians who discussed the findings from the first phase of the study and
provided feedback on these findings. The focus group also discussed barriers and
solutions to incorporating these findings in TC treatment services. The results from
the first phase indicated that elevated anxiety and depression scores at entry to
treatment were strong predictors of client retention at 8 weeks, and retention at 14
weeks was predicted by high self-esteem scores at entry. Clients receiving medication
(primarily anti-depressant medication) were more likely retained at 14 weeks. Older
clients (24 – 29 years, and 30 – 50 years) were significantly more likely to drop out of
treatment by the 14 week stage compared with the younger client group (17 – 24
years).
The second stage revealed general agreement with the findings, provided
support for the efficacy of TC treatment for clients with comorbid mental health
problems, highlighted challenges and benefits of working with mental health services,
and suggested other factors influencing treatment retention. The first stage findings
contribute to the understanding of TC treatment retention factors with an Australian
population, but do not support previous findings that female clients, younger clients,
clients with elevated anxiety or depression scores, or clients with methamphetamine
abuse problems are more likely to drop out of TC treatment.
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This study involved the collection of a large client database from a single TC
over six years, including the longitudinal collection of client psychometric data at
various stages throughout treatment. This study makes an important contribution to
the understanding of various client factors and their respective influence on client
retention and attrition within an Australian therapeutic community. The study has
relevance for residential substance abuse treatment services in many countries, but has
special relevance within Australia where few studies focusing on TC retention have
been undertaken. There have been even less studies focusing on TC retention that
have included longitudinal psychometric data collected from a client population
primarily comprised of young methamphetamine-users.
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Introduction
Significance of This Study
Substance abuse continues to be a major social, health and economic problem
in many countries. Scott, Dennis, Laudet, Funk, and Simeone (2011) report U.S.
research indicating that individuals with a drug dependence diagnosis on average die
22.5 years earlier than those without such a diagnosis. The authors also report the
finding that 2.8 % of the U.S. population (6.9 million persons) currently meet the
diagnostic criteria for substance abuse disorders (Scott, et al., 2011, p. 737).
Increasing the effectiveness of substance abuse treatment is consequently an
important health and economic goal for many nations. Substance abuse treatment
programs can be divided into outpatient and inpatient programs, and inpatient
programs are commonly called residential programs. Residential programs are
typically regarded as more expensive to operate than outpatient programs; however
they remain a common form of substance abuse treatment, especially for persons with
more severe substance abuse problems. Therapeutic communities are a particular
form of residential substance abuse treatment that are usually structured in a
hierarchical manner with residents expected to take increasing responsibility within
the community as they progress with their recovery. Therapeutic communities are
often utilised by persons who have a history of substance abuse treatment failure,
more severe substance abuse problems, unstable living conditions, involvement with
criminal activity, and injecting drug users (De Leon, 2000). The effectiveness of
many forms of substance abuse treatment is predicted by the length of time in
treatment, and yet premature treatment attrition remains common, especially from
residential treatment programs, including TCs. Although the typical duration of client
stay in TC treatment programs during the 1960’s and 1970’s was 2-3 years, it is now
common for TC programs to be only 3, 6 or 12 months long (De Leon, 2000, p.3).
Attrition from these modern shorter TC programs remains a major barrier however for
the provision of effective treatment. Obtaining a better understanding of the factors
that predict client retention and attrition from TCs has therefore been the focus of
much published substance abuse treatment research in recent decades.
Previous studies examining factors that contribute to treatment retention in
therapeutic communities for people with substance abuse problems have almost
Therapeutic Community Retention
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always been conducted in the United States and Western Europe. There have been
very few published studies examining treatment retention in Australian TCs. A
comparison of US and Australian national household studies of substance abuse notes
many significant differences in the patterns of substance abuse between these two
countries (Maxwell, 2008). The author notes many significant differences between
Australia and US prevalence rates of life-time use of various types of substances, and
states that since 1998 substance use within Australia has decreased significantly for
most drugs (excluding alcohol and ecstasy), however use of most illicit drugs in the
US has increased. As substance abuse patterns and populations can differ significantly
between countries, it is important to better understand treatment retention factors in
Australian TC’s, because there may be significantly different patterns of substance
abuse and cultural norms that may influence treatment retention and attrition.
Within a particular country there may also be significant differences between
patterns of substance abuse and the profile of the treatment population. An example of
this within-country difference is that during the period of this data collection there
was a greater proportion of the AOD treatment population presenting with
methamphetamine problems in Western Australia compared to eastern states
(Australian Institute of Health and Welfare, 2006). It is therefore probable that these
within-country differences in population substance-using profile will be reflected in
differing treatment retention rates due to the influence of factors believed to influence
client treatment retention (e.g. primary drug of abuse and mental health difficulties).
Another potentially confounding factor of adopting findings from various TC
retention studies is there is often significant variation between these programs,
including beliefs about addiction and substance abuse recovery. These differences
may manifest as differences in therapeutic content, therapeutic emphasis, program
structure, staffing structure, and support services. These program differences are
sometimes termed program factors, and it is increasingly common to include or note
these factors in recent studies of client treatment retention (Curran, Stecker, Han, &
Booth, 2007). The significant program structure and staffing variations between some
TC’s mean that these program factor differences may have a confounding influence
on retention findings. The relevance of some TC program factors to client retention
and attrition is explored and discussed in the second stage of this thesis.
The present study is, therefore, a very useful addition to the knowledge base of
client retention and attrition from Australian TCs because it contains a large sample of
Therapeutic Community Retention
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client data obtained from one Western Australian TC program that maintained
continuity of most of the various differential program factors mentioned above during
the 6-year period of data collection. The data is also important because it contains
longitudinal measures of client psychometric data following treatment entry. This data
is useful for analysing changes in mental health and well-being during the course of
withdrawal from various substances and the following initial weeks of abstinence that
can contribute to a better understanding of co-morbidity. This study makes a
significant contribution towards improved understanding of client factors predicting
attrition and retention from TCs, including an improved understanding of the
dynamics of client mental health functioning after initiating abstinence.

Economic Costs of Substance Abuse
Residential services have often been regarded as an expensive option for the
treatment of substance abuse; however the higher cost of this form of treatment needs
to be understood in the context of the overall cost to society of substance abuse. This
section will present some estimates of the costs of substance abuse in various
countries during recent decades. Determining the total costs of substance abuse is a
complex task involving calculation of various direct and indirect costs to the
individual and the state. This task is made especially difficult because substance abuse
involves many substances including alcohol, tobacco, and various illicit substances.
The related costs for all these substances are therefore, estimated in most cases,
especially the various costs associated with illicit drug use. Although complex, cost
determination of substance abuse is required to help guide policy makers and public
health planners. Many countries report costs associated with alcohol use only, because
the figures are more transparent and more easily determined than including costs of
illicit substance abuse.
The estimated 1998 annual costs of alcohol abuse in the United States of
America (USA) were US$148 billion (Harwood, 2000). The added costs of other
forms of substance abuse in the USA are likely to increase this figure significantly.
For example, a RAND Corporation study reported that the 2005 costs of
methamphetamine abuse in the USA was $23.4 billion (Rand Organisation, 2009).
The costs of alcohol consumption to the United Kingdom’s (UK) National Health
Service (NHS) in 2001 was estimated at 1.47 billion pounds, and increased to 2.7
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billion pounds by 2006/2007 (NHS, 2010). The same 2010 NHS report notes that
alcohol is the third leading cause of disease burden in developed countries.
Thavorncharoensap, Teerawattananon, Yothasamut, Lertpitakpongand, and
Chaikledkaew (2009) undertook a review of the cost of alcohol abuse in various
countries, and suggested that the relative costs of alcohol consumption may be more
easily understood when the costs are stated as a percentage of a country’s Gross
Domestic Product (GDP). The authors report that in the 12 countries selected for their
analysis, the economic burden of alcohol consumption equated to between 0.45 –
5.44% of GDP for each country.
A series of studies have been undertaken within Australia in recent decades to
determine the total cost of alcohol, tobacco and other drug abuse that highlight the
increasing costs of these problems to Australian society. The authors stated that
almost one in every five deaths within Australia between 1988 and 1992 had drugrelated causes (Collins & Lapsley, 1996). A determination of the 1998/1999 costs by
the same authors estimate tangible social costs of A$5.045 billion for illicit drugs,
A$6.12 billion due to alcohol, and A$11.92 billion attributed to tobacco abuse
(Collins & Lapsley, 2002). The most recent analysis by Collins and Lapsley (2008) of
the total costs of tobacco, alcohol and illicit drug abuse within Australia during
2004/2005 states that total costs for that year exceeded A$55 billion, and noted that
tobacco accounts for A$31.5 billion, alcohol A$15.3 billion, and illicit drugs A$8.2
billion.
A recent breakdown of Australian Government spending on illicit drug policy
in 2002/2003 revealed that total costs were $3.2 billion, and that state governments
accounted for approximately 70% of this spending. This figure was comprised of $1.3
billion on proactive expenditure, of which 55% was devoted to law enforcement, 23%
to prevention, 17% to treatment, 3% to harm reduction and 1% to activities spanning
several of those areas (Moore, 2008). Expenditure on the consequences of illicit drug
use was estimated to be another $1.9 billion, and the large majority of this amount
was crime-related costs. The author notes that this illicit drug cost policy mix
breakdown is very similar to cost breakdowns reported in other western countries.
There is no evidence to suggest the costs of substance abuse have decreased in
Australia and other countries in more recent years, and given the significant social and
economic costs of substance abuse to these countries, there is no doubting the need to
reduce costs where possible. Significant resources are devoted to education and policy
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to control alcohol abuse, and policing, border protection, judicial and incarceration
costs to reduce the supply of illicit substances. Another method of reducing the costs
of substance abuse is to reduce on-going demand for substances by providing more
effective substance abuse treatment programmes. There are various models of
intervention for treating substance abuse and some of these models are resource
intensive and require significant initial investment, and recurrent state and private
funding.
There have been no published comprehensive studies examining the costeffectiveness of substance abuse treatment in general within Australia; however
Ciketic, Hayatbakhsh, Doran, Najman and McKetin (2012) recently completed a
review within Australia of various treatments for methamphetamine abuse. The
authors noted the difficulty of determining treatment efficacy due to the heterogeneity
of treatments, the lack of treatment protocols by many treatment services, and the
difficulty of consequently determining the cost-effectiveness of various treatment
approaches. Further complicating an accurate determination of substance abuse
treatment cost-effectiveness is the heterogeneity of treatment presentations by
individuals who may or may not present with a wide range of comorbid physical and
mental health problems that are likely to have significantly different treatment needs,
and costs. Despite the limitations in determining the cost-effectiveness of various
treatment interventions, in the last decade there has been considerable research
examining the cost-effectiveness of various substance abuse treatment programmes in
the USA and the U.K.
A study of 43 Californian substance abuse treatment providers during
2000/2001 reported that the average treatment cost per individual was $1,583, and
that this was associated with a monetary benefit to society of $11,487 per treated
individual, (Ettner, Huang, Evans, Ash, Hardy, Jourabchi, & Hser, 2006). The authors
note this cost saving primarily represents a reduction in the cost of crime and
increased employment earnings. However, there are many other unaccounted cost
savings from improved health and quality of life for the individuals concerned.
Despite this, the savings reported represent a greater than 7:1 ratio of benefits to costs,
and the authors note that investment in substance abuse treatment is obviously costeffective.
Potential cost savings from effective substance abuse treatment will generally
be greater with young persons, however some research findings have reported specific
Therapeutic Community Retention
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difficulties treating young persons for substance abuse problems because they are
believed to be more likely to drop out of treatment compared with older clients (Hser,
Grella, & Hubbard, Hsieh, Fletcher, Brown, & Anglin, 2001). Attempts to improve
substance abuse treatment for adolescents have included the establishment of
specialised substance abuse treatment services for adolescents; however, these
specialist services are often expensive. King, Gaines, Lambert, Summerfield, and
Bickman (2000) report a study of 428 adolescents that estimated the average
treatment cost for each person was $13,067. The authors note, however, that for a
subset of the young persons studied who were diagnosed with a comorbid disorder,
the average treatment costs were more than double at $29,057. The authors note that
comorbid mental health problems in adolescents with substance abuse problems
presents more complex treatment demands that account for the higher average cost of
treatment. Comorbidity is common in substance abuse populations and Chan, Dennis,
and Funk (2008) report the findings of a large study involving 4,930 adolescents and
1,956 adults admitted to various substance abuse treatment centres in the USA. They
note that two thirds of clients had a co-occurring mental health problem in the year
prior to treatment, and that young adults were found to be most vulnerable clients for
having co-occurring mental health problems.
There has been fast growing awareness of comorbidity in all age groups within
the substance abuse treatment population field during the last decade. This has raised
many questions for researchers, policy makers and clinical staff about treatment
options, treatment effectiveness and cost-effectiveness of various substance abuse
programs in meeting the needs of clients with complex substance abuse problems.
Determining the cost-effectiveness of substance abuse programs has therefore also
needed to account for the fact that a large proportion of the presenting population
have more than one disorder, and that analyses of treatment effectiveness should
consider the effects of intervention across multiple domains in client lives to more
accurately determine the potential costs and cost savings of suitable treatment.

Measuring Substance Abuse Treatment Effectiveness
The topic of evaluating treatment effectiveness has been a complicated and
contentious issue in the substance abuse treatment field for many years (Sindelar,
Jofre-Bonet, French, & McLellan, 2004). The authors note that many service
providers and researchers believe treatment effectiveness should be measured on a
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single scale, which is achieving and sustaining abstinence from substance abuse. The
goal of abstinence in these more traditional substance abuse treatment programmes is
determined from a philosophy of treatment that is commonly termed the “disease
model”. For example, Alcoholics Anonymous and Narcotics Anonymous are two
large organisations operating in many western countries within the substance abuse
treatment field that suggest that abstinence is the only acceptable goal of treatment.
Much research into addictive behaviours published in recent decades
suggested that brief returns or “lapses” to substance abuse are part of the process of
unlearning chronically habitual behaviour, and do not necessarily represent failure or
relapse (Saunders & Houghton, 1996). This recognition that recovery from substance
abuse treatment is a process over time has led to the acceptance and adoption by many
public policy makers and treatment programmes of the legitimacy of harm
minimisation goals rather than abstinence as the only acceptable goal for substance
abuse treatment services.
Harm minimisation philosophy recognises that many individuals are either
unable, or unwilling, to stop using various substances completely, therefore harm
minimisation treatment goals may be utilised to reduce the level of substance use so
there is less disruption in the person’s life. Another common harm minimisation goal
might be to ensure that their drug use is safe, and this may typically involve teaching
people about safe syringe use and disposal to reduce the risk of blood-borne disease.
Researchers have recognised that it is more appropriate to measure substance abuse
treatment effectiveness across multiple domains, including reduced drug use,
improved psycho-social functioning, reduced crime and increased employment
(Sindelar et al., 2004). This issue of appropriate treatment goals often overlaps with
common differences between the clinical aims of inpatient versus outpatient treatment
programmes. Inpatient services generally retain the goal of abstinence from all
substance abuse, at least during the inpatient programme, whereas many outpatient
programmes adopt harm minimisation or substance use reduction goals. An
Australian review of long-term residential treatment services reported that 66% of the
56 Australian services reviewed reported having an abstinence treatment philosophy
(Ernst & Young Consulting Team, 1996). The following section will briefly describe
what is meant by inpatient or residential substance abuse treatment services.
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Residential Substance Abuse Treatment
Residential services play an important role in providing substance abuse
treatment in the USA and the UK, and other western countries (Gossop, Marsden,
Stewart, & Rolfe, 1999). The cost-effectiveness of residential substance abuse
treatment services has been queried, however, because it is generally regarded as
more expensive than outpatient treatment. In response to those claims, McGeary,
French, Sacks, McKendrick, and DeLeon (2000) report that when the costs of
increased number of hospital days and emergency visits by outpatient clients were
considered, residential treatment and outpatient treatment costs were similar.
Other studies of inpatient treatment for substance abuse have focused on
whether inpatient treatment is more effective than outpatient treatment or drug
substitute modalities such as methadone programmes. Mattick, Baillie, Grenyer, Hall,
Jarvis, and Webster (1993) reported there is limited evidence to suggest inpatient
treatment for alcohol problems was more effective than outpatient treatment. More
recently, however, the Drug Outcome Research in Scotland study (DORS) noted that
clients in residential services were more likely to achieve 90 day abstinence rates than
clients in all other forms of substance abuse treatment (McKeganey, Bloor,
Robertson, Neale, & MacDougall, 2006). There is also the realisation that poor people
with no employment and insecure housing may benefit more from residential
interventions than they would benefit from outpatient interventions.
There are complexities when comparing substance abuse treatment modalities,
because client treatment goals may differ greatly, effectiveness is measured
differently by different modalities and programmes, and there are high levels of
heterogeneity in programs even with a similar modality (Ettner, Huang, Evans, Ash,
Hardy, Jourabachi, & Hser, 2006). Researchers also need to follow up clients to
determine post-treatment outcomes; however this is difficult as client populations are
often homeless and difficult to maintain in longitudinal research programmes. Despite
these difficulties in obtaining meaningful comparisons of treatment outcomes of
different treatment modalities, several studies have reported that residential treatment
services are more effective than outpatient services engaging persons with co-morbid
mental health problems and those with housing problems (Nuttbrock, Ng-Mak,
Rahav, & Rivera, 1997; McKeganey et al., 2006). Etheridge, Hubbard, Anderson,
Craddock, and Flynn (1997) also note that persons with more severe substance abuse
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problems are more likely to require more intensive interventions than what is
normally offered in community settings.
It should also be noted that residential treatment for substance abuse can take
various forms. In some situations the residential service is provided by a public or
private clinic or hospital where detoxification or medically-managed withdrawal
occurs initially, and is then typically followed by a period of individual and group
counselling in the clinic or hospital. These clinic and hospital-based programs tend to
be shorter-term programs of only a few weeks duration, and are often utilised by
persons with more social support, and a more structured life including stable
employment and housing. Other residential treatment programmes are designed to
cater for persons with more complex problems and these programmes may have a
residential duration of between 28 days to a year of more. Many of these longer-term
residential programmes are described as therapeutic communities, and the following
section will describe this specific type of residential treatment service and some of the
research findings relating to their effectiveness.

Therapeutic Communities
Therapeutic communities (TCs) have existed in the substance abuse treatment
field for about 50 years. TCs are a specific form of substance abuse treatment using
residential programs structured in a hierarchical manner involving various treatment
stages reflecting increasing levels of personal and social responsibility. TCs primarily
differ from other styles of residential substance abuse treatment by their use of staff
and residents as key agents of change with an approach that has been termed
“community as method” (De Leon, 2000, p. 92). TCs typically use a hierarchical
model of treatment that occurs in several stages with the aim of increasing residents’
personal and social responsibility (NIDA Research Report, 2002). TCs have become a
common form of residential treatment for substance abuse in many western countries;
however their cost-effectiveness has been questioned over the decades.
Gowing, Cooke, Biven, and Watts (2002) reviewed the TC outcome literature
and reported that there is little evidence to support the claim that TCs are more
effective than other forms of substance abuse treatment. The authors did note,
however, that there was substantial research evidence that TC treatment is associated
with reduced drug use and criminality, improved health and psychological
functioning, and increased involvement in work, education and training. Lees,
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Manning, and Rawlings (2004) undertook a meta-analysis of 29 published studies of
TC treatment effectiveness where TC programs had been compared with various other
control interventions or control institutions. The authors noted several difficulties
obtaining randomised controlled trials of TCs in the published literature, especially
given that TC entry criteria may be complex and that the variety of treatment
outcomes that may be chosen for comparison in different studies. Despite these
limitations, they note that their analysis indicated that most published studies reported
that TC treatment outcomes were more effective than the various control programs
and institutions across the multiple domains compared.
There have been many studies in the last two decades reporting that the style
of treatment practised in therapeutic communities has adapted to suit changing
substance abuse populations and funding requirements. In particular, the recognition
that many individuals seeking substance abuse treatment have mental health
difficulties has required many TCs to specialise or modify their normal practices. The
specialised TCs are often referred to as “modified TCs” and they usually have a less
demanding program structure with reduced emphasis on confrontational group work
(De Leon, 2000). Brunette, Mueser, and Drake (2004) undertook an analysis of
controlled studies of AOD residential services including many TCs, and noted that
TCs were more effective in helping persons with multiple problems (especially clients
with comorbid mental health problems) if they were able to appropriately integrate
mental health services within their substance abuse service. There has been
considerable research in recent decades to determine how to better engage, assess,
treat and retain comorbid populations in residential substance abuse treatment
services, including TCs.
Sacks, Banks, McKendrick, and Sacks (2008) report a recent analysis of four
studies comparing various forms of standard treatment versus treatment within
therapeutic communities that had been modified for clients with co-occurring severe
mental health disorders. The authors note that the modified TCs had better treatment
outcomes for clients with mental health comorbidities across several measures and
domains including substance use, mental health, crime, HIV risk, employment and
obtaining stable housing after treatment. The authors also note that the differences in
outcomes varied between studies and further research is required to better clarify the
factors that contribute to treatment effectiveness with this population.
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TC outcome research indicates that the most consistent indicator of positive
treatment outcomes in all modified and standard TC programmes is the amount of
time the person spent in treatment (Greenfield, Burgdorf, Chen, Porowski, Roberts, &
Herrell, 2004). In particular, 90 days has often been reported in recent decades as the
minimum time that should be spent in a TC or residential service to be of benefit
(Baker, Gowing, Lee, & Proudfoot, 2004; Messina, Wish, & Nemes, 2000). Various
factors have been hypothesised to influence TC treatment retention, and the following
section will discuss these substance abuse treatment retention research findings.

Treatment Retention
Many researchers have reported that the amount of time spent in inpatient
substance abuse treatment is positively correlated with successful treatment outcome
where abstinence is the given definition of success (De Leon, Melnick, Kressel, &
Jainchill, 1994; Hubbard, Craddock, & Anderson, 2003; Simpson, Joe, Fletcher,
Hubbard, & Anglin, 1999). Brewer, Catalano, Haggerty, Gainey, and Fleming (1998)
report the results of a meta-analysis of opiate treatment studies in which short periods
of treatment (less than 8 weeks) and leaving treatment prematurely were significant
predictors of substance abuse relapse. Although time in treatment appears to be the
strongest predictor of successful substance abuse treatment outcome, Baker, Gowing,
Lee, & Proudfoot (2004, p.80) note, “but this is a complex issue with time being
something of a proxy indicator for engagement, participation and progress in
treatment.” There is general agreement among researchers in this field that the amount
of time in AOD treatment programs is a strong predictor of successful outcome,
however there remains mixed findings of the client factors hypothesised to predict
treatment attrition. The following sections discuss some of the client factors that have
been commonly reported by researchers as predicting AOD treatment attrition.

Retention and Gender
Women are often under represented in AOD treatment research studies with
researchers noting existing substance abuse treatment models have been informed by
primarily studying men (Sun, 2006). Many studies have reported that women are
more likely than men to drop out of inpatient substance abuse treatment prematurely
(Copeland & Hall, 1995; De Leon et al., 1994; Haller, Miles, & Dawson, 2002). It has
also been suggested that female substance abuse is closely linked to comparatively
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poorer psychological functioning with higher rates of co-morbidity, especially
depression and suicidal ideation (Allen, 1994; Copeland & Hall, 1995; Hser, Huang,
Teruya, & Anglin, 2004; Wilke, 2004).
Messina, Wish, and Nemes (2000) analysed data from 412 clients (116
females and 296 males) who had sought substance abuse treatment and were
randomly assigned to two different TCs followed by a period of outpatient care. Both
men and women who completed the longer 12 month program were much less likely
to relapse, commit crime or be unemployed, compared to males and females who
attended the shorter six month TC program. The authors noted that the women in this
sample had been abusing drugs for approximately 10 years with a high degree of
previous criminal involvement and appeared to benefit from longer-term residential
services more than the males in the sample. There were no significant gender
differences for completion of the longer 12 month program.
Greenfield, Brooks, Gordon, Green, Kropp, McHugh, Lincoln, Hien, and
Miele (2007) reviewed the substance abuse treatment outcome literature from 1975 to
2005. They noted that almost half the number of women compared to men develop
substance abuse problems, and are much less represented in substance abuse treatment
populations and related research studies. The authors also noted that, when women do
seek treatment, they often present with more severe mental health and social
problems, and may have different needs compared to males in treatment. Greenfield et
al. (2007) found no evidence that women-only substance abuse treatment programmes
were more effective for women than mixed-gender programmes, but did note there
was considerable evidence that addressing specific needs of women within mixedgender programmes is effective. The authors found that, once in treatment, gender is
not a significant predictor of treatment retention, completion or outcome. Sun (2006)
reviewed the substance abuse treatment literature, and reported findings of 35 womenonly treatment services and studies with separate gender findings from mixed-gender
treatment services. The author notes that nine studies reported that women only
programs had better treatment retention than mixed-sex programs, but notes that most
of the studies had significant design limitations.
In summary, there does not appear to be consistent findings that genderspecific treatment services reliably produce improved treatment retention or other
improved treatment outcomes. More recent research has focused on the specific needs
of females in substance abuse treatment including program factors hypothesised to
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affect female retention in residential treatment. In general, there has been little
published research on Australian substance abuse residential treatment samples
comparing treatment attrition rates of males and females. Specifically, there is little
published Australian research examining gender differences in psychological
functioning during residential treatment for women with substance abuse problems.

Retention and Age
Client age has often been noted as a factor predicting treatment outcome
following substance abuse treatment. It is commonly believed by many AOD
treatment clinical staff that older clients have more likely “hit bottom” (this is a term
often used in the AOD treatment field to describe the client with an overwhelming
number of problems in multiple domains of their life due to their substance abuse). It
is commonly believed that these older clients are more likely to be motivated to
complete treatment than younger clients with less complex problems. Supporting
these common AOD staff perceptions that older clients are usually more motivated to
undertake and complete treatment than younger clients are research findings that
adolescents and young adults are less likely to be retained in substance abuse
treatment programmes (Williams & Chang, 2000).
Grella, Hser, Joshi, and Anglin (1999) reported on the Drug Abuse Treatment
Outcome Studies (DATOS) that analysed outcomes of 551 clients in long-term (12
months) residential services with outcomes of 571 clients in outpatient programs. The
authors found that younger clients (less than 30 years) stayed in treatment for fewer
days than older clients in both outpatient treatment counselling and residential
modalities. The authors suggested that, although retaining younger clients in treatment
was more difficult, the benefits of retention for long-term treatment success were
apparent and therefore the problem of retaining younger persons in treatment needed
to be better understood. Joe, Simpson and Broome (1999) also analysed the DATOS
findings and reported that younger clients tended to remain less days in treatment for
all substance abuse treatment modalities.
Recent research by Adams, Peden, Hall, Rayens, Staten, and Leukefeld (2011)
of female offenders in a community-based residential substance abuse facility
indicated that older women were much more likely to remain in treatment than
younger women, although the authors note that this was a particularly vulnerable
population with concerns about future employment. Satre, Mertens, Arean, and
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Weisner (2004) followed up 925 former clients 5 years after treatment and reported
outcomes according to client age. The authors found that older adults (55-77 years)
had been retained in treatment longer than middle-aged (40-54 years) or younger (1839 years) clients, and the older client group were more likely to be abstinent 5 years
later than younger and middle-age groups. Analysis of these outcomes revealed that
age group was not the most significant factor predicting 5-year outcomes, and that
other variables such as gender, treatment retention, primary drug of abuse and social
networks had greater effect in predicting 5-year AOD abstinence rates. Although there
are obviously other confounding factors affecting long-term outcomes, there remains
the common finding that younger persons tend to remain in most AOD treatment
modalities for shorter periods of time compared to older clients.

Retention and Self-Esteem
Various client attributes have been studied to determine if there are possible
links to the aetiology of substance abuse, and recovery from substance abuse.
Research has indicated that low self-esteem in both men and women is implicated in
the development of alcohol use disorders, and women with low self-esteem are also at
risk of developing drug use disorders (Trucco, Connery, Griffin, & Greenfield, 2007).
Low self-esteem has been associated with alcohol and other drug abuse with
researchers noting that low self-esteem is common in both outpatient and inpatient
treatment populations (Malcolm, 2004). Females presenting for maintenance
treatment for opiate abuse have reported lower self-esteem than men, and this was
suggested to be closely related to the high rate of depression in women seeking
substance abuse treatment (Giacomuzzi, Riemer, Ertl, Rossler, Hinterhuber, & Kurz,
2005).
In recognising that persons low in self-esteem are more at risk of developing
substance abuse problems, increasing client self-esteem is often included as a goal in
substance abuse treatment interventions. However, the relationship between changes
to client self-esteem and successful substance abuse treatment is unclear.
Improvement in self-esteem scores during substance abuse treatment for women
appears to be an important factor predicting treatment success (Wilke, 2004), but the
findings for males are less clear. Malcolm (2004) reported on a sample of homeless
men receiving outpatient substance abuse treatment where self-esteem scores
decreased concurrent with a general decrease in the group’s alcohol and other drug
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use. Hawke, Hennen, and Gallione (2005) reported outcomes from a study of 185
adolescent males from five New Jersey therapeutic community programs, and note
that a measure of therapeutic involvement was a strong predictor of treatment
retention and outcome. The measure of therapeutic involvement was comprised of
numerous factors, but further analyses indicated that self-esteem was a strong
component predicting therapeutic involvement and retention. Dekel, Benbenishty,
and Amran (2004) reported that both male and female clients with higher self-esteem
were more likely to be abstinent at 15 months post-treatment compared to clients with
lower self-esteem in a study of 167 heroin addicts from 3 TCs in Israel.
Trucco et al., (2007) conducted a relatively small study (41 women and 60
men), but provided an interesting analysis of the association of self-esteem with
substance abuse treatment. The authors reported that at treatment entry low selfesteem was associated with depression and other psychiatric disorders in both men
and women, but that self-esteem was not related to relapse or one-year post treatment
drinking outcomes, gender or self-efficacy. They further noted that the definition of
self-esteem is unclear and that many studies have collapsed measures of self-efficacy
with self-esteem and self-concept.
The research suggests that self-esteem scores may be an important predictor of
treatment retention and attrition for female and younger clients in particular.
However, the mixed findings reported in the literature suggest that the relationship
between self-esteem and substance abuse treatment completion requires further
clarification. Many studies of substance abuse treatment retention and client selfesteem have also noted a strong relationship between client self-esteem and
concurrent measures of anxiety and mood.

Retention and Anxiety and Mood Disorders
The most common coexisting disorders with alcohol and other substance
abuse are anxiety and affective disorders (Donohue, Acierno, & Kogan, 1996; Scott,
Gilvarry, & Farrell, 1998). Scott et al. (1998) reviewed the findings of clinical
samples from the United Kingdom and reported that 28% of individuals with a
substance abuse problem will also have an anxiety problem, and 26% will have an
affective disorder. McKenna and Ross (1994) estimated that at least 50% of
individuals who abuse alcohol and/or other drugs have at least one comorbid
psychiatric disorder. The National Survey of Mental Health and Wellbeing
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(NSMHWB) undertaken with an Australian population in 2007 noted high rates of
comorbidity between alcohol and other drug use disorders and mental health issues
(Mills, Deady, Proudfoot, Sannibale, Teeson, Mattick, & Burns, 2007). The authors
reported that the most common comorbid mental health issues in the population
abusing alcohol and other drugs were mood, anxiety and personality disorders.
Many drug treatment retention/attrition studies have reported that clients with
substance abuse and psychiatric comorbidity have higher rates of treatment attrition
and relapse (Charney, Paraherakis, Negrette, & Gill, 1998; Miller, 1992; Moos,
Mertens, & Brennan, 1994). However, Meier and Best (2006) reported an analysis of
United Kingdom residential treatment services for substance abusers and noted that
the proportion of dual-diagnosis rates within these samples did not appear to influence
retention rates. A review of 58 treatment outcome studies undertaken by Meier and
Barrowclough (2009) provides a recent summary of research on this question. The
authors noted that a past history of mental health problems did not predict treatment
attrition. However, evidence for current mental health problems affecting substance
abuse treatment attrition was contradictory. They noted that most treatment retention
research studies have focused on the effects of affective disorders, anxiety disorders
and personality disorders as they are the most common mental health problems
reported by the majority of studies. They note that most clients in substance abuse
treatment with concurrent anxiety, mood and most personality disorders are not more
likely to drop out, however clients with anti-social personality disorder are at elevated
risk of attrition.
The high prevalence of current comorbidity in substance abuse treatment
populations is nevertheless reported by many researchers to contribute to low
treatment retention rates, and it is often noted that psychiatric disorders need to be
accurately identified and addressed during substance abuse treatment to improve
retention rates. As previously described, during the last 20 years many therapeutic
community programmes have modified the style and content of their programmes
with the aim of improving retention rates for clients with mental health problems.
Tailoring interventions in therapeutic communities to better retain residents with
mental health problems suggests the need for accurate diagnoses, however obtaining
definitive mental health diagnoses is often complicated with substance abusing
populations.
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Co-existing Versus Substance-induced Disorders
Several researchers dispute the high prevalence figures reported for current
psychiatric comorbidity in substance abuse treatment populations (Charney et al.,
1998; Grant et al., 2004; Raimo & Schuckit, 1998). Curran, Booth, Kirchner, and
Deneke (2007) stated that, in the case of mood disorders, many studies have failed to
distinguish coexisting disorders from temporary symptoms of substance intoxication
and withdrawal because assessment is usually undertaken on admission to treatment,
soon after or during the substance abuse withdrawal period. They noted that
significant positive change in patient psychopathology usually occurs in the
immediate weeks following admission to substance abuse treatment and suggested
that these cases are not representative of mood disorders independent from the
substance abuse problem.
More accurate prevalence rates of comorbidity in substance abuse treatment
populations would be better determined by measuring anxiety and depressive
symptoms following the withdrawal period from substance abuse. Curran et al. (2007)
suggest the discrimination between major depressive episodes and substance-induced
mood disorders requires a detailed time-line evaluation of the client, but note that
most symptoms of substance-induced depression resolve within four weeks of
abstinence. Baker, Kay-Lambkin, and Lee (2009) note the high frequency of anxiety
and mood disorders in substance abuse treatment populations suggests screening for
these problems should be undertaken in AOD treatment services. The authors make
the important note that this should be undertaken with assessment tools that have been
specifically validated for use with alcohol and other drug service clients after the
clients have completed the active phase of substance use withdrawal.
Many studies have noted that females have high depression levels at treatment
entry, but there are a limited number of studies examining treatment retention and
changes in psychopathology in substance abuse treatment populations that include
female participants (Brooner, King, Kidorf, Schmidt, & Bigelow, 1997; Greenfield et
al., 2007). Curran et al., (2007) reported on a male sample showing elevated
depression scores at treatment exit are a predictor of relapse within three months of
treatment cessation, but noted that elevated depression scores at treatment entry in this
sample did not reliably predict treatment attrition.
A recently published analysis of 227 cocaine dependent individuals in 6 TCs
in Spain reported high rates of co-occurring psychiatric morbidity for these persons
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(65.6%), with mood, anxiety and psychotic disorders predominating. The authors
describe the use of a semi-structured questionnaire designed to help discriminate
independent or primary psychiatric disorders, from substance-induced disorders. They
were consequently able to determine that the large majority of both mood and
psychotic co-occurring psychiatric disorders were substance-induced psychiatric
disorders. The authors note that the finding has important ramifications for how
integrated mental health treatment should be implemented within TCs to best effect
(Vergara-Moragues, Gonzalez-Saiz, Lozano, Espinosa, Calderon, Bilbao-Acebos,
Garcia & Garcia, 2012). In regard to the implementation of integrated mental health
treatment within substance abuse treatment settings, Sterling, Chi & Hinman (2011)
note that although there is considerable evidence for the benefits of integrated mental
health care, a variety of practical and ideological barriers remain within many U.S.
substance abuse treatment settings, and note that only about half of the U.S. AOD
services offer dual AOD and mental health treatment. The authors note that some of
these barriers may relate to the primary form of substance abuse that services treat,
and the next section focuses on reported findings of primary drug of abuse and
treatment retention.

Retention and Primary Drug of Abuse
Persons entering substance abuse treatment programmes are usually required
to indicate to the service the primary drug or substance that has been problematic for
them in recent times, and this is usually termed the person’s “primary drug of abuse”.
Treatment services typically service populations where various substances have been
indicated as the “primary drug of abuse”, and recognise that persons often abuse
multiple substances. Most residential services therefore do not alter or tailor the
treatment programme according to the person’s identified primary drug of abuse.
However, many service staff believe people gravitate to the use and abuse of specific
substances for various personal reasons that may or may not be effectively addressed
in a particular treatment programme. Many researchers have hypothesised that an
individual’s primary drug of abuse may be important in determining whether the
person remains in treatment, however the research findings regarding whether a
person’s primary drug of abuse helps predict their retention in various forms of
substance abuse treatment have been mixed.
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There were no significant differences reported by Copeland and Sorensen
(2001) in a North American sample regarding the successful completion of outpatient
treatment for stimulant users in a study comparing cocaine and methamphetamine
users. Patkar, Thornton, Mannelli, Hill, Gottheil, Vergare, and Weinstein (2004)
measured treatment outcomes of 143 individuals receiving 12-week substance abuse
outpatient treatment and noted no significant differences in treatment completion rates
when comparing the alcohol, cocaine and multi-substance abusing groups. More
recently, however, Meier and Best (2006) conducted a survey of 57 AOD residential
rehabilitation services in England and Wales, and noted that treatment completion
rates were significantly lower for programmes with more clients admitted for illicit
drug problems than for alcohol problems. There does not appear to be any consistent
finding reported in the literature for any particular primary drug of abuse affecting
treatment retention.
The majority of AOD treatment attrition studies in the previous twenty years
have been undertaken in either the USA or Western Europe and have focused on
populations where alcohol, opiates and cocaine were the primary drugs of abuse.
There is increasing concern during the last two decades about methamphetamine
abuse in Australia, North America and many Asian countries, and yet there has been
limited research undertaken with clients presenting to Australian inpatient treatment
facilities with this class of drug as the primary presenting drug problem (Australian
Institute of Health and Welfare, 2002). There has been considerable research
undertaken in North American with this particular population group during the last
decade. Luchansky, Krupski, and Stark (2007) studied all adults and youth admitted
to Washington State substance abuse treatment services in 2003. They found that both
adult and youth clients who identified methamphetamines as their principal drug of
use had shorter episodes of both inpatient and outpatient treatment, and were less
likely to have positive outcomes compared to clients identifying alcohol and cannabis
as their primary drug of abuse. Hillhouse et al., (2007) reported findings from their
study of 420 methamphetamine abusing adults that females and persons with high
depression levels were less likely to successfully engage with substance abuse
treatment for methamphetamine abuse. The authors also noted there has been little
published research identifying predictors of treatment retention and completion with
methamphetamine abusing populations.

Therapeutic Community Retention

31

Retention and Methamphetamines
There is limited understanding of comorbidity and psychopathology change
following abstinence with methamphetamine treatment populations in particular
(Dawe & McKetin, 2004). Few substance abuse inpatient treatment population studies
have reported changes in psychopathology during treatment, and even fewer have
examined gender differences in psychopathology change. A focus on changes in client
psychopathology within the methamphetamine-abusing treatment population is also
rare within the research literature. Dyer and Cruickshank (2005) reported findings of
an analysis of methamphetamine abusing clients seeking detoxification in Western
Australia, and reported moderate to high levels of depression in this sample, however
the authors noted that further research is required to further determine the relationship
between depression and treatment outcome with this population.
Rawson et al., (2000) found that methamphetamine users reported
significantly higher depression scores than cocaine users and that these elevated
scores persist for longer periods of time and negatively affect treatment retention.
These authors noted that elevated depression scores persist among some former
methamphetamine abusers even years after treatment. In contrast to this report of
persistent elevated depression scores among former methamphetamine abusers,
McGregor et al., (2005) stated that the majority of withdrawal symptoms with
methamphetamine users resolve within the first week of withdrawal, including
depression symptoms. This study only involved a small sample (n = 21) that included
a single female participant. Lin et al., (2004) conducted a larger study of incarcerated
Taiwanese methamphetamine users (n = 325, including 145 females), where 37% of
the sample reported psychiatric problems. No significant gender differences were
reported for mood disorders with this sample; however there was no analysis of
psychopathology change following drug use cessation.
A review of relevant literature by Baker and Dawe (2005) focussed on
describing the prevalence and course of the most common co-occurring psychological
problems with methamphetamine users. These authors state there has been very little
investigation of the psychopathology course of methamphetamine use and cooccurring psychological problems. They also note that diagnostic certainty requires a
substantial period of abstinence. Baker and Dawe (2005) also state that
psychopathology scores should be measured at least 2 weeks after initiation of
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abstinence, and preferably measured repeatedly during treatment to better determine
the role of depression and anxiety in treatment retention.
Gonsalves, Sapp and Huss (2007) report findings of a recent study comparing
methamphetamine and non-methamphetamine users entering a U.S. short-term
residential dual diagnosis treatment facility, and note that the methamphetamine subpopulation were more likely to be younger, and to drop out of treatment early
compared to non-methamphetamine users. Darke, Kaye, McKetin, and Duflou (2008)
report a review of the major physical and psychological harms of methamphetamine
use, and note that compared to normal populations, high rates of substance-induced
psychosis, depression and anxiety are reported by users.
Ciketic, Hayatbakhsh, Doran, Najman, and McKetin (2011) report an analysis
of the effectiveness of various outpatient and inpatient treatment interventions for
persons with methamphetamine problems, and note that there are very low rates of
methamphetamine treatment access within Australia despite the fact that Australia has
one of the highest rates of methamphetamine use in the world. It remains possible that
these low treatment rates of methamphetamine users within Australia may reflect that
treatment services are not meeting the mental health needs of this client group, and
therefore methamphetamine users who do access treatment are therefore more likely
to drop out.

Retention and Prescribed Psychoactive Medication
Determining a more accurate clinical picture of client psychopathology after
in-patient entry has important ramifications for treatment content and service policy.
An accurate determination of whether a mood disorder exists or is primarily a shortterm function of substance withdrawal may help determine whether continued specific
psychological or pharmacological interventions are warranted.
Until relatively recently, the use of medication for mental health disorders was
discouraged or disallowed in many substance abuse treatment settings in the USA
(Brady & Verdun, 2005). Knudsen, Ducharme, and Roman, (2007) conducted a more
recent national study of 766 substance abuse treatment centres in the USA, and noted
that less than half of these treatment centres allowed client use of SSRI medications
for mood disorders. The frequency of use of prescribed medication for psychiatric
disorders within Australian residential AOD treatment facilities is more difficult to
determine, because there has been little published research of Australian residential
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treatment services in general, and what has been published usually does not indicate
whether clients are allowed prescribed medication use during residential treatment.
The difficulty with some AOD residential treatment services prohibiting the
use of prescribed psychoactive medications is that, many persons seeking to enter
“drug free” residential AOD treatment services will abruptly cease taking prescribed
medications to qualify for entry. One problem with abrupt cessation of prescribed
psychoactive medications immediately prior to residential service entry is many
individuals

may

experience

substance

abuse

withdrawal

symptoms

with

accompanying increased mental distress symptoms. Escalation of mental symptoms
and decreased mental well-being due to entry to a novel environment, concurrent with
withdrawal from substance use and various prescribed medications may possibly
contribute to the high rates of early treatment attrition witnessed in many residential
AOD treatment services.
Lynskey (1998) reported that a number of placebo-controlled studies have
indicated treatment for alcohol dependence may be enhanced with anti-depressant
medication. The large majority of AOD treatment studies focusing on attrition rates in
residential services do not indicate whether prescribed psychoactive medications are
available to clients. It is possible that reported treatment attrition rates are influenced
by service policy regarding the exclusion or availability of prescribed medications for
clients experiencing mental health problems (Knudsen, Ducharme, & Roman, 2007).

Summary
Most analyses of AOD residential treatment services (including therapeutic
communities) conclude that residential treatment is an effective form of intervention
for individuals with various substance abuse problems. High treatment attrition rates
in residential interventions are common however, and many studies have therefore
sought to identify causes of attrition from residential substance abuse treatment.
Various client and program factors have been identified in individual studies that
predict client attrition; however, there is no consensus of what are reliable attrition
factors, and the search for factors influencing attrition is complicated by many
variables. Some of the attrition factors that have been identified in the literature
include client gender, age, mental health status, and primary drug of abuse.
There are a large number of studies examining retention and attrition in
residential treatment settings in the USA, and a smaller number of studies of United
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Kingdom and other European treatment services, but little published literature
examining client retention and attrition in Australian AOD residential or TC treatment
services. It is important to undertake research with Australian TC treatment services,
as there are different population mixes and some different patterns of substance abuse
compared to other countries that may influence client treatment retention.
In recent years there have also been numerous research findings stating that
persons entering residential treatment with methamphetamine-use problems are much
more likely to drop out of treatment, and that many of these clients have comorbid
mental health problems. Australia continues to have high rates of methamphetamine
use, and so this study also seeks to better understand if methamphetamine-using
clients are at much higher risk of TC attrition. The second stage of this study involved
presenting the findings of the first stage to experienced managers and senior clinicians
of Australian and New Zealand TCs for comment and reaction. The primary aim of
the second stage is to help determine the validity and utility of the stage one findings
from the perspective of TC senior staff, and to explore possible barriers and solutions
to introducing knowledge of the stage one findings to TCs.

Stage 1 Research Aims
It is possible, on the basis of past findings, to hypothesise that gender, age,
primary drug of abuse and client psychopathology are factors that may influence
AOD inpatient treatment attrition. However, past findings are inconsistent in their
identification of whether these factors influence inpatient treatment attrition. The aim
of the first study reported in this thesis was to examine several of these previously
reported predictors of retention and attrition in an Australian therapeutic community.
More specifically the study aimed to examine the association between gender, age
group, primary drug of abuse, medication use, self-esteem, anxiety and depression
scores at entry, at 2-weeks and at 8-weeks, and treatment retention at 8 and 14 weeks,
and explore hypotheses generated from past research findings.
Hypothesis 1 is that both male and older clients will be more likely retained in
treatment at both 8 weeks and 14 weeks.
Hypothesis 2 is that clients nominating methamphetamines as their primary
drug of abuse will be more likely to drop out of treatment by 8 weeks and 14 weeks.
Hypothesis 3 is that clients with elevated anxiety and depression scores will be
more likely to remain in treatment at 8 weeks and 14 weeks.
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Stage 1 Method
Participants
The sample consisted of 234 adults (150 males, 84 females) who voluntarily
entered a Western Australian therapeutic community (Palmerston Farm) during a sixyear period (2000-2005). The agency client database for the period of data collection
contains no personal-identifying information and is comprised of client data
indicating age, gender, primary substance of abuse, medication use, and psychological
test scores (depression, anxiety and self-esteem), that were collected by the agency for
client monitoring purposes throughout the period of clients’ substance abuse
treatment.
The client demographic data were routinely collected by administrative staff
soon after client entry to the TC program. The psychometric data were collected by
clinical staff at entry, and then re-measured during the second, eighth and fourteenth
weeks of remaining clients. The psychometric data remained in client files to allow
clinician monitoring of client mental health throughout their period of treatment.
Agency staff transcribed client demographic and psychometric data from client files
on an annual basis, and this de-identified information was electronically stored on a
secure, dedicated archive at the agency. This author was later granted access by the
Chief Executive officer of the Agency to use the de-identified client data archive for
the purpose of this research.

Participant Demographics

Client Age
Preliminary analysis of the frequencies of the treatment entry data resulted in
the decision to separate the data into three age groups of approximately even numbers.
These three categories are; 17-23 years inclusive (n = 77), 24-29 years (n = 80) and
30-50 years (n = 77).

Client Gender
There were 150 males and 84 females at treatment entry.
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Stage 1 Materials
The psychometric measures of anxiety, self-esteem and depression were selected by
the drug treatment agency involved due to their availability at no charge, and their
recommendation for AOD agency use by the Western Australian Best Practice in
Alcohol and Other Drug Interventions Working Group’s publication: “A Guide for
Counsellors Working with Alcohol and Other Drug Users” (Marsh & Dale, 2000).

Self-esteem
•

Rosenberg Self-Esteem Scale (RSE) - (Rosenberg, 1989).

The Rosenberg Self-Esteem (RSE) Measure is a 10-item, 4-point scale measure,
originally designed to measure the self-esteem of high school students. However,
since its development in 1965 the scale has been used with many different populations
from a large variety of occupations. Extensive research has demonstrated concurrent,
known-groups, predictive and construct validity of the RSE, and it correlates highly
with other self-esteem measures, and in predicted directions with commonly used
measures of anxiety and depression. The RSE has a Guttman scale coefficient of
reproducibility of .92, indicating excellent internal consistency, and 2-week test-retest
reliability correlations of .85 indicating very high internal stability (Fischer &
Corcoran, 1994). The scale produces scores from 10-40 with higher scores indicating
greater self-esteem. Scores were divided into 3 categories: 10-20 (low); 21-30
(medium); and 31-40 (high). Items in the scale include; “I feel that I have a number of
good qualities”, “I take a positive attitude towards myself”, and “I feel that I’m a
person of worth, at least on an equal plane with others”.

Depression
•

The Centre for Epidemiological Studies Depression Scale (CES-D) (Radloff,
1977)

The CES-D is a 20-item scale designed to measure depression in the general
population. However, it has also been used with clinical and psychiatric populations.
The instrument is easily used, extensively researched and has broad applicability. The
CES-D has excellent concurrent validity and correlates well with a range of other
depression and mood scales. It has good known-groups validity and discriminates
well between psychiatric inpatients and the general population, and moderately well
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between levels of severity within patient groups. The CES-D has good internal
consistency with alphas of .85 in the general population and .90 in the psychiatric
population. The CES-D also has acceptable test-retest correlations ranging from .51 to
.67 (tested from two to eight weeks). This measure has also been shown to be
sensitive to measuring change in psychiatric status after treatment (Fisher &
Corcoran, 1994). Items in the CES-D include; “I was bothered by things that usually
don’t bother me”, “I had trouble keeping my mind on what I was doing”, “I felt that
everything I did was an effort”, and “I felt depressed”.

The CES-D produces scores ranging from 0-60, with scores above 16 indicative of
depressed mood, and scores above 26 indicative of major depression (Ensel, 1986;
Zich & Attkinson, 1990). Depression categories used for this analysis were: 0-15
(Normal); 16-26 (indicative of Mild Depression); 27-60 (indicative of Major
Depression).

Anxiety
•

Mind Over Mood Anxiety (MOM-A) Inventory ( Greenberger & Padesky, 1995)

This scale was recommended for use with substance abuse treatment populations by
Marsh and Dale (2000) and has been used by several AOD treatment services in
Western Australia. Little research has been published on this inventory although Cox,
Beal, and Brittain (2005) report results of a concurrent validity study comparing the
Mind over Mood Inventory with the Beck Anxiety Inventory (BAI) and the Burns
Anxiety Inventory (Burn’s-A) with a group of 100 undergraduate students. Cox et al.
state that the MOM-A correlation with the Burn’s-A was 0.849, (p <.01), and the
correlation with BAI was 0.724 with the Beck Anxiety Inventory.

The Mind Over Mood Anxiety instrument presented difficulties in determining
commonly accepted categories of anxiety scores because this instrument has not been
cited in previous research. The 24 item measure produces scores from 0-72, and in the
absence of suggested categorical scoring for this instrument, the scores were divided
into three approximately equal categories using a method described by Keller, (2005):
Class width = (maximum score – minimum score/ number of classes). This method
resulted in 3 anxiety classifications: 0-24 (low anxiety), 25-48 (medium anxiety), and
49-72 (high anxiety). The instrument asks respondents to rate how much they have
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experienced symptoms in the previous week, and test items include; “Feeling
nervous”, “Sweating not due to the heat”, “Avoiding places where I might feel
anxious”, and “Rapid heartbeat”.

Psychoactive Medication Use
Prescribed

client

psychoactive

medications

included

anti-depressant

medication (primarily Selective Serotonin Re-uptake Inhibitor type, or SSRI), antipsychotic medications, and mood stabiliser medications. The large majority of
prescribed client medications were the SSRI anti-depressant class of medication, with
smaller numbers of clients prescribed various mood stabiliser and anti-psychotic
medications. At entry there were 151 clients not taking medications, 67 clients taking
anti-depressants, 12 clients prescribed anti-psychotics, and 4 clients prescribed mood
stabilising medications. A small number of clients had also been prescribed
Naltrexone; however this was not recorded in the database. The small number of
clients prescribed medications other than anti-depressants did not allow their separate
analysis effect on client treatment retention. Client use of any medication was
therefore collapsed into a single Medication Use variable, with two levels,
“Medication Use” or “No Medication Use”.

Primary Drug of Abuse
On treatment entry clients are asked to name their current primary drug of use,
resulting in four primary drug categories comprising amphetamines (principally
methamphetamine, however the two terms are used inter-changeably throughout this
paper), alcohol, opiates and cannabis. It should be noted that, from the year 2000,
there was a reduction in the local availability of opiates (heroin) in Western Australia,
and a sharp and sustained increase in the availability and illicit use of
methamphetamines. The change in patterns of primary drug of abuse from opiates and
alcohol to methamphetamines presented major challenges for most Western
Australian AOD residential treatment services at that time. The methamphetamineusing population were usually younger males who were commonly presenting to
AOD treatment services with a range of mental health problems. This population soon
became the major client group in most Western Australian treatment services during
those years. It should be noted that Methamphetamines are primarily labelled as
Amphetamines in most of the frequency and analysis tables within the results section.
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Stage 1 Procedure
Written permission was obtained from the AOD Agency to assess and analyse
the residential treatment facility’s client database from the 2000-2005 period (see
Appendix D). The researcher was provided with an electronic copy of the database
that was copied to the researcher’s private computer. This data file was password
protected on the researcher’s private computer. The database contains non-identifiable
client data and corresponding psychological test scores collected as standard clinical
practice during that period of operation. The psychometric data collection points of
the residential service occurred at program entry, then 2, 8 and 14 weeks after entry.
For the purpose of this analysis, and to allow comparisons with past research findings,
the 8 and 14 week points in the treatment program were chosen as the times to
measure client treatment retention. Analysis of the data using a statistical package
(Statistical Package for the Social Sciences, SPSS, Version 19) identified variables
indicating a significant association with retention and attrition risk at the 8 and 14week stages of treatment.
Analysis of 14-week retention in treatment was chosen for the purpose of
exploring the 3-month period of treatment that previous research analysing AOD
treatment retention and longer-term outcomes had stated was significant (Simpson,
Joe, Broome, Hiller, Knight, & Rowan-Szal, 1997). Other research analysing
retention rates in residential programmes have used similar 90 day retention periods,
(Baker, Gowing, Lee, & Proudfooot, 2004; Brunette, Mueser, & Drake, 2004).
The 8-week time period in this research was chosen by agency clinicians to
help discriminate substance–induced elevated psychiatric symptoms from elevated
symptoms attributed to distinct mental health disorders. Gossop, Marsden, and
Stewart (2006) noted that many clients entering substance abuse treatment have
psychiatric symptoms that significantly decrease usually within the first month of
abstinence. Senior clinicians of the T.C. service also believed that methamphetamine
withdrawal was more complicated in some individuals, and suspected that
improvement in psychiatric symptoms could continue over an extended period of up
to 8 weeks.
The psychopathology data were also collected at 2 weeks; however the
archived client data indicated that only nine clients left treatment during the first two
weeks. The agency clinical staff believed this comparatively small number of client
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dropouts in the initial two-week period was a reflection of the agency’s stringent entry
conditions to the TC. Client entry to this TC involved continuous proof of abstinence
in the two weeks immediately prior to entry as determined by at least twice weekly
outpatient urinalysis. The residential service clinical staff believed this period of preentry abstinence provided a significant motivational “test” to help avoid early client
attrition. This pre-admission period was also believed to help protect existing clients
from new arrivals who can subsequently leave on impulse soon after arrival. The 2week pre-admission procedure also protected the agency from medical complications
in the event of complicated substance abuse withdrawal, as the service is located in a
rural area and is unable to easily obtain medical assistance on site.
It was decided that this small number of clients (nine clients) leaving treatment
during the initial 2-week period provided insufficient change in retention numbers to
offer any meaningful results of possible effects of the various independent variables.
Data from the 2-week period following entry were therefore not analysed.

Stage 1 Data Analysis
The first stage of data analysis involved use of Binary Logistic Regression
using SPSS (Statistical Package for the Social Sciences, Version 19). Binary logistic
regression analysis is a useful statistical method when there is a dichotomous
dependant variable (e.g., treatment retention or attrition), and allows the relative
contributions of multiple independent variables (e.g., gender, primary drug, age,
psychoactive medication use, psychological test scores) to be determined (Cizek &
Fitzgerald, 1999) and expressed as an odds ratio (OR).

Stage 1 Independent Variables
Independent variables in the analysis include age, gender, primary drug of
abuse, use of prescribed psychoactive medications, and measures of anxiety,
depression and self-esteem. All continuous variables (e.g. age, and the anxiety,
depression and self-esteem measures), were converted into approximately equal
categories to better enable interpretation and use of the results in stage 2 of the study.
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Stage 1 Results
The sample of 234 clients was comprised of 150 males and 84 females at program
entry. By 2 weeks, the sample was reduced to 143 males and 82 females, or 96.1% of
the original sample. By 8 weeks the sample had further reduced to 104 males and 59
females, or 69.6% of the original sample. At 14 weeks, 67 males and 33 females, or
42.7% of the original sample remained in the program.

Table 1
Independent variable frequencies at specific program times
Independent

Number at

Number at

Number at

Number at

Variables

Entry

2 weeks

8 weeks

14 weeks

Male

150

143

104

67

Female

84

82

59

33

(18 – 24)

77

76

46

30

(25 – 29)

80

74

60

29

(30 – 50)

77

75

57

41

Amphetamines

132

128

89

56

Opiates

31

29

21

9

Alcohol

44

43

33

23

Cannabis

27

25

20

12

Anti-depressant

67

67

49

25

Anti-psychotic

12

12

9

4

Other

4

4

2

1

All Medication:

83

83

60

30

No medication

151

142

103

70

Gender

Age Group

Primary Drug

Medication

Depression level
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Low (0 – 15)

43

49

72

57

Medium (16 – 26)

61

88

68

34

High (27 – 60)

130

88

23

9

Low (0 – 24)

86

124

132

86

Medium (25 – 48)

134

99

30

14

High (49 – 72)

14

2

1

0

Low ( 10 – 20)

2

0

0

0

Medium (21 – 30)

153

113

38

12

High (31 – 40)

79

112

125

88

Totals

234

225

163

100

Anxiety Level

Self-Esteem Level

Table 1 summarises frequency change of the independent variables over time, and
indicates that rates of attrition are reasonably similar within gender, age and the
primary drug categories.

The following tables Nos. 2 to 13 are cross-tabulations of several of the independent
variables that have been included to better describe data frequencies between some of
the variables, and changes of key variable frequencies (depression levels) over time.
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Table 2
Client Gender X Age Group at Program Entry
Age group

Male

Female

Total

17-23

24-29

30-50

Total

Count

48

56

46

150

% within Client Gender

32.0%

37.3%

30.7%

100.0%

% within Age group

62.3%

70.0%

59.7%

64.1%

Count

29

24

31

84

% within Client Gender

34.5%

28.6%

36.9%

100.0%

% within Age group

37.7%

30.0%

40.3%

35.9%

Count

77

80

77

234

% within Client Gender

32.9%

34.2%

32.9%

100.0%

% within Age group

100.0% 100.0% 100.0% 100.0%

Table 2 provides the number and percentage of males in females at entry according to
the three age groupings and indicates that the age group distributions of male and
female clients were similar.
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Table 3
Primary Drug of Abuse X Age Group
Age group

Amphetamines

Opiates

Alcohol

Cannabis

Total

Total

17-23

24-29

30-50

Count

51

50

31

132

% within Primary Drug

38.6%

37.9%

23.5%

100.0%

% within Age group

66.2%

62.5%

40.3%

56.4%

Count

8

13

10

31

% within Primary Drug

25.8%

41.9%

32.3%

100.0%

% within Age group

10.4%

16.3%

13.0%

13.2%

Count

5

10

29

44

% within Primary Drug

11.4%

22.7%

65.9%

100.0%

% within Age group

6.5%

12.5%

37.7%

18.8%

Count

13

7

7

27

% within Primary Drug

48.1%

25.9%

25.9%

100.0%

% within Age group

16.9%

8.8%

9.1%

11.5%

Count

77

80

77

234

% within Primary Drug

32.9%

34.2%

32.9%

100.0%

% within Age group

100.0%

100.0%

100.0%

100.0%

Table 3 shows the age groupings of the entire sample at entry according to primary
drug of abuse. In this table it can be seen that primary drug of abuse was associated
with age, and that amphetamines/methamphetamines were nominated as the primary
drug of abuse by 66.2% of the 17 – 23 year old group, 62.5% of the 24-29 year old
group, and 40.3% of the 30-50 year old group. The large majority (65.9%) of persons
nominating alcohol as their primary drug were in the older age group, and 48.1% of
persons nominating cannabis as their primary drug were in the youngest group.
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Table 4
Medication Use X Age Group
Age group

No Medication

17-23

24-29

30-50

Total

Count

48

51

52

151

% within

31.8%

33.8%

34.4%

100.0%

% within Age group

62.3%

63.7%

67.5%

64.5%

Count

29

29

25

83

% within

34.9%

34.9%

30.1%

100.0%

% within Age group

37.7%

36.3%

32.5%

35.5%

Count

77

80

77

234

% within

32.9%

34.2%

32.9%

100.0%

+ or - Medication

Any Medication

+ or - Medication

Total

+ or - Medication
% within Age group 100.0% 100.0% 100.0% 100.0%

Table 4 shows the three age groupings of the sample at entry according to medication
use and indicates that medication use at program entry was unrelated to age of client.
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Table 5
Client Gender X Depression Level at Entry
Depression level at Entry
Low

Male

High

Total

(0 - 15) (16 - 26)

(27 - 60)

Count

32

45

73

150

% within Client Gender

21.3%

30.0%

48.7%

100.0%

% within Depression level 74.4%

73.8%

56.2%

64.1%

11

16

57

84

13.1%

19.0%

67.9%

100.0%

% within Depression level 25.6%

26.2%

43.8%

35.9%

Count

43

61

130

234

% within Client Gender

18.4%

26.1%

55.6%

100.0%

100.0%

100.0%

Female Count
% within Client Gender

Total

Medium

% within Depression level 100.0% 100.0%

Table 5 shows depression levels at program entry for male and female clients, with a
greater percentage of females (67.9%) reporting high levels of depression at entry,
compared to males (48.7%).
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Table 6
Client Gender X Anxiety Level at Entry
Anxiety Level at Entry

Male

Female

Total

Total

Low

Medium

High

(0 - 24)

(25- 48)

(49- 72)

65

77

8

150

% within Client Gender

43.3%

51.3%

5.3%

100.0%

% within Anxiety Level

75.6%

57.5%

57.1%

64.1%

21

57

6

84

% within Client Gender

25.0%

67.9%

7.1%

100.0%

% within Anxiety Level

24.4%

42.5%

42.9%

35.9%

86

134

14

234

% within Client Gender

36.8%

57.3%

6.0%

100.0%

% within Anxiety Level

100.0%

100.0%

100.0%

100.0%

Count

Count

Count

Table 6 shows anxiety levels at program entry and indicates that both males and
females primarily reported low to medium levels of anxiety at entry, with a higher
percentage of males reporting low anxiety levels compared with females.
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Table 7
Client Gender X Self-Esteem Level at Entry
Self-Esteem Level at Entry

Male

Low

Medium

High

Total

(10 - 20)

(21 - 30)

(31 - 40)

Count

2

94

54

150

% within Gender

1.3%

62.7%

36.0%

100.0%

% within Self-

100.0%

61.4%

68.4%

64.1%

Count

0

59

25

84

% within Gender

.0%

70.2%

29.8%

100.0%

% within Self-

.0%

38.6%

31.6%

35.9%

Count

2

153

79

234

% within Gender

.9%

65.4%

33.8%

100.0%

% within Self-

100.0%

100.0%

100.0%

100.0%

Esteem Level
Female

Esteem Level
Total

Esteem Level

Table 7 shows self-esteem levels for male and female clients at program entry and
indicates that the large majority of clients enter the program with medium levels of
self-esteem (62.7 % of males, and 70.2% of females).
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Table 8
Primary Drug of Abuse X Client Gender

Female

Total

85

47

132

56.7%

56.0%

56.4%

20

11

31

13.3%

13.1%

13.2%

23

21

44

15.3%

25.0%

18.8%

22

5

27

14.7%

6.0%

11.5%

150

84

234

100.0%

100.0%

100.0%

Male
Amphetamines

Opiates

Alcohol

Cannabis

Total

Table 8 indicates that the majority of both male (56.7%) and female (56.0%) clients
noted amphetamines/methamphetamines as their primary drug of abuse. Remaining
males nominated cannabis (14.7%), opiates (13.3%), and alcohol use (15.3%) as their
principal drugs of abuse; and the remaining females nominated cannabis (6.0%),
opiates (13.1%) and alcohol (25.0%) as their principle drugs of abuse.
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Table 9
Client Gender X Psychoactive Medication Type
No Medication

Male

Female

Total

Anti-

Anti-

Other

Total

Depressants

Psychotics

Medication

104

34

9

3

150

(69.3% of males)

(22.7%)

(6.0%)

(2.0%)

(100%)

47

33

3

1

84

(55.9% of females)

(39.3%)

(3.6%)

(1.2%)

(100%)

151

67

12

4

234

(64.5% of clients)

(28.6%)

(5.1%)

(1.7%)

(100%)

Table 9 indicates more males (69.3 %) than females (55.9 %) were not prescribed
medications. A higher proportion of females (39.3 %) compared to males (22.7 %)
were prescribed anti-depressant medications. A higher proportion of males (6.0 %)
were prescribed anti-psychotic medication compared to females (3.6%).
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Table 10
Depression Level at Entry X Medication Use
Depression level at Entry

Total

Low

Medium

High

(0 - 15)

(16 - 26)

(27 - 60)

Count

36

39

76

151

% No Medication

23.8%

25.8%

50.3%

100.0%

% Depression level at Entry

83.7%

63.9%

58.5%

64.5%

Any

Count

7

22

54

83

Medication

% With Medication

8.4%

26.5%

65.1%

100.0%

% Depression level at Entry

16.3%

36.1%

41.5%

35.5%

Count

43

61

130

234

% within + or - Medication

18.4%

26.1%

55.6%

100.0%

% Depression level at Entry

100.0%

100.0%

100.0%

100.0%

No Medication

Total

Table 10 indicates the majority of clients prescribed medications scored in the high
depression level at program entry (65.1% of all medicating clients), and medium
depression level at entry (26.5% of all medicating clients). It should also be noticed
that 50.3% of the clients taking no medications scored in the high level of depression
at entry, and 25.8% scored in the medium level of depression.
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Table 11
Depression Level at 2 Weeks X Medication Use
Depression level at 2 Weeks
Low

Medium

High

(0 - 15)

(16 - 26)

(27 - 60)

Total

No

Count

40

56

46

142

Medication

% No Medication

28.2%

39.4%

32.4%

100.0%

% Depression level at 2 Weeks

81.6%

63.6%

52.3%

63.1%

Any

Count

9

32

42

83

Medication

% With Medication

10.8%

38.6%

50.6%

100.0%

% Depression level at 2 Weeks

18.4%

36.4%

47.7%

36.9%

Count

49

88

88

225

% within + or - Medication

21.8%

39.1%

39.1%

100.0%

% within Depression level at 2

100.0%

100.0%

100.0%

100.0%

Total

Weeks

Table 11 indicates that there was a general decrease in the number of persons in the
high levels of depression to the medium and low levels of depression for both the
medicating and non-medicating clients at 2 weeks compared to the numbers of person
in high depression levels at entry (Table 10).
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Table 12
Depression Level at 8 Weeks X Medication Use
Depression level at 8 Weeks

Total

Low

Medium

High

(0 - 15)

(16 - 26)

(27 - 60)

Count

53

39

11

103

% No Medication

51.5%

37.9%

10.7%

100.0%

% Depression level at 8 Weeks 73.6%

57.4%

47.8%

63.2%

Any

Count

19

29

12

60

Medication

% With Medication

31.7%

48.3%

20.0%

100.0%

% Depression level at 8 Weeks 26.4%

42.6%

52.2%

36.8%

Count

72

68

23

163

% + or - Medication

44.2%

41.7%

14.1%

100.0%

100.0%

100.0%

100.0%

No Medication

Total

% Depression level at 8 Weeks 100.0%

Table 12 indicates decreasing numbers and percentages of clients remaining with high
levels of depression at 8 weeks within both medication and non-medication groups.
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Table 13
Anxiety Level at Entry X Medication Use

Entry Anxiety level

low (0 - 24)

No

Any

Total

Medication

Medication

Count

60

26

86

% within + or -

39.7%

31.3%

36.8%

Count

81

53

134

% within + or -

53.6%

63.9%

57.3%

Count

10

4

14

% within + or -

6.6%

4.8%

6.0%

Count

151

83

234

% within + or -

100.0%

100.0%

100.0%

Medication
Medium (25- 48)

Medication
High (49- 72)

Medication
Total

Medication

Table 13 indicates a lower percentage of medicating clients in the low anxiety level
group (31.3%), compared to non-medicating clients at entry (39.7%). There was a
higher percentage of medicating clients in the medium anxiety level (63.9%) group
compared to the non-medicating clients (53.6%).

Therapeutic Community Retention

55

Table 14
Primary Drug of Abuse X Psychiatric Medication Type
No

Anti-

Medication

Depressant Psychotic Medication Total

91

36

5

0

132

60.3%

53.7%

41.7%

.0%

56.4%

Count

22

7

0

2

31

% within

14.6%

10.4%

.0%

50.0%

13.2%

Count

23

19

0

2

44

% within

15.2%

28.4%

.0%

50.0%

18.8%

Count

15

5

7

0

27

% within

9.9%

7.5%

58.3%

.0%

11.5%

Count

151

67

12

4

234

% within

100.0%

100.0%

100.0%

100.0%

100.0%

Amphetamines Count
% within

Anti-

Other

Medication
Opiates

Medication
Alcohol

Medication
Cannabis

Medication
Total

Medication

Table 14 indicates the breakdown of medication type by primary drug of use, and
reveals that anti-psychotic medication was prescribed to clients who had reported that
either methamphetamines, or cannabis as their primary drug problem. Anti-depressant
medication was the most common medication, and had been prescribed to: 36 (27.3%)
of methamphetamine users, 7 (22.5%) of opioid users, 19 (43.2%) of alcohol users,
and to 5 (18.5%) cannabis users. “Other medications” were comprised of Naltrexone
that had also been prescribed to two opioid users, and mood stabilising medications
had been prescribed to 2 alcohol users.
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Prediction of retention at 8 weeks:
The primary questions posed in stage 1 of this thesis concerned prediction of retention
in the program at eight and fourteen weeks. By eight weeks, of the original 234 clients
(150 males and 84 females) only 163 (69.7%) remained (104 males and 59 females).
In this initial set of 7 analyses, the variables of gender, age, drug of abuse, use of
medication, level of anxiety, depression and self-esteem assessed on entry into the
program were progressively entered into a series of binary logistic regression
equations predicting retention as a method of preliminary exploration of the data.
Significant results (p < .05) are identified in bold type within the tables.

Table 15
Analysis No. 1 for Gender Predicting Retention at 8 Weeks
Step 1a

p

Exp(B)

95% C.I. for Exp(B)

Gender

.885

0.958

0.535

Constant

.000

2.360

1.715

Gender was not a significant predictor of retention at 8 weeks.

Table 16
Analysis No. 2 for Gender and Age Group Predicting Retention at 8 Weeks
Step 1a

p

Exp(B)

95% C.I. for Exp(B)

Gender(1)

.821

0.934

0.518

1.685

Age group

.128

0.588

0.298

1.161

.732

1.133

0.554

2.316

.001

2.778

(18 – 24 years)
Age group (1) .126
(25 – 29 years)
Age group (2)
(30 – 50 years)
Constant

Age group and gender in the equation were not significant predictors of 8 week
retention.
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Table 17
Analysis No. 3 for Gender, Age Group and Primary Drug Predicting Retention at 8
Weeks
Step 1a

p

Exp(B)

95% C.I. for Exp(B)

Gender(1)

.738

0.903

0.496

1.643

Age Group

.128

Age Group(1)

.181

0.609

0.295

1.259

Age Group(2)

.594

1.224

0.582

2.573

Drug

.563

.195

0.518

0.191

1.400

.266

0.505

0.151

1.685

.539

0.687

0.208

2.272

.009

4.700

(Amphetamines)
Drug(1)
(Opiates)
Drug(2)
(alcohol)
Drug(3)
(Cannabis)
Constant

Gender, age group and primary drug type were not significant predictors of 8 week
retention.
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Table 18
Analysis No. 4 for Gender, Age Group, Primary Drug Type and Medication Use
Predicting Retention at 8 Weeks
Step 1a

p

Exp(B)

95% C.I. for Exp(B)

Gender(1)

.822

0.933

0.510

1.708

Age Group

.122

Age Group(1)

.161

0.594

0.286

1.231

Age Group(2)

.639

1.195

0.567

2.519

Drug

.636

Drug(1)

.225

0.539

0.198

1.464

Drug(2)

.299

0.527

0.157

1.766

Drug(3)

.532

0.683

0.207

2.257

Medication(1)

.432

0.781

0.421

1.447

.006

5.358

(Any medication)
Constant

Medication use was not a significant predictor of 8 week retention when gender, age
and primary drug were also included in the model.
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Table 19
Analysis No. 5 for Gender, Age Group, Primary Drug Type, Medication Use and
Anxiety Levels at Entry Predicting Retention at 8 Weeks
Step 1a

p

Gender(1)

.865

Age Group

.127

Age Group(1)

Exp(B)

95% C.I. for Exp(B)

0.947

0.503

1.783

.188

0.602

0.283

1.282

Age Group(2)

.550

1.261

0.590

2.697

Drug

.633

Drug(1)

.248

0.549

0.199

1.517

Drug(2)

.318

0.531

0.154

1.836

Drug(3)

.637

0.743

0.217

2.547

Medication Group(1)

.562

0.828

0.439

1.565

Anx Lev Ent

.006

Anx Lev Ent(1)

.012

5.313

1.446

19.524

.002

7.572

2.141

26.775

.841

0.839

(Medium anxiety)
Anx Lev Ent(2)
(High anxiety)
Constant

Medium and high anxiety levels were significant predictors of 8 week retention when
gender, age group, primary drug and medication use were also included in the
equation. The medium level of anxiety at entry was significant (OR = 5.313, 95% C.I
= 1.446/19.524, p = .012). The high level of anxiety was also significant (OR = 7.572,
95% C.I. = 2.141/26.775, p = .002), indicating that the groups with medium or high
level of anxiety at entry were significantly more likely to be retained at 8 weeks.
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Table 20
Analysis No. 6 for Gender, Age Group, Primary Drug Type, Medication, Anxiety and
Depression Levels at Entry Predicting Retention at 8 Weeks
Step 1a

p

Exp(B)

95% C.I. for Exp(B)

Gender(1)

.632

0.854

0.446

1.632

Age Group

.088

Age Group(1)

.149

0.564

0.259

1.228

Age Group(2)

.519

1.290

0.595

2.796

Drug

.659

Drug(1)

.244

0.539

0.190

1.526

Drug(2)

.308

0.513

0.142

1.849

Drug(3)

.559

0.687

0.195

2.423

Medication Group(1)

.660

0.862

0.446

1.667

AnxLevEnt

.011

AnxLevEnt(1)

.034

4.628

1.121

19.102

.003

6.680

1.880

23.735

(Medium Anxiety)
AnxLevEnt(2)
(High Anxiety)
DepLevEnt

.032

DepLevEnt(1)

.790

0.879

0.340

2.270

.021

2.719

1.162

6.362

.857

0.852

(Med Depression)
DepLevEnt(2)
(High Depression)
Constant

With the addition of depression levels into the previous equation, the medium level of
anxiety at entry was significant (OR = 4.628, 95% C.I. = 1.121/19.102, p = .034), and
high levels of anxiety at entry was significant (OR = 6.680, 95% C.I. = 1.880/23.735,
p = .003). The high level of depression at entry was also significant (OR = 2.719, 95%
C.I. = 1.162/6.362, p = .021). Clients with medium and high levels of anxiety at entry,
and high level of depression at entry were significantly more likely retained at 8
weeks.
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Table 21
Analysis No. 7 for Gender, Age Group, Primary Drug Type, Medication, Anxiety,
Depression and Self-Esteem Levels at Entry Predicting Retention at 8 Weeks
Step 1a

p

Gender(1)

.610

Age Group

.063

Age Group(1)

Exp(B)

95% C.I. for Exp(B)

0.844

0.439

1.623

.166

0.574

0.261

1.259

Age Group(2)

.377

1.429

0.647

3.160

Drug

.635

Drug(1)

.225

0.516

0.177

1.503

Drug(2)

.289

0.492

0.133

1.824

Drug(3)

.528

0.664

0.186

2.371

MedicationGroup(1)

.765

0.903

0.465

1.756

AnxLevEnt

.019

AnxLevEnt(1)

.059

4.034

0.948

17.163

AnxLevEnt(2)

.006

6.024

1.659

21.871

DepLevEnt

.018

DepLevEnt(1)

.675

1.251

0.440

3.561

DepLevEnt(2)

.008

3.517

1.398

8.852

SELevEnt

.240

SELevEnt(1)

1.000

0.999

0.047

21.460

.096

1.870

0.894

3.910

.531

0.549

(Med Self-esteem)
SELevEnt(2)
(High Self-esteem)
Constant

Self-esteem level at entry did not predict retention at 8 weeks when added to the other
variables in the equation. The high level of anxiety at entry was significant (OR =
6.024, 95% C.I. = 1.659/21.871, p = .006). The high level of depression at entry was
also significant (OR = 3.517, 95% C.I. = 1.398/8.852, p = .008). The groups with high
level of anxiety of depression were more likely retained in treatment at 8 weeks.
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Table 22
Analysis No. 8 for Gender, Age Group, Primary Drug Type, Medication, Anxiety,
Depression and Self-Esteem Levels at 2 Weeks Predicting Retention at 8 Weeks
Step 1a

p

Exp(B)

95% C.I. for Exp(B)

Gender(1)

.705

0.881

0.456

1.700

MedicationGroup(1)

.979

0.991

0.513

1.916

Age Group

.039

Age Group(1)

.141

0.558

0.257

1.213

Age Group(2)

.349

1.489

0.647

3.424

Drug

.274

Drug(1)

.054

0.311

0.095

1.022

Drug(2)

.177

0.380

0.093

1.550

Drug(3)

.224

0.426

0.108

1.687

AnxLev2

.619

AnxLev2(1)

.999

0.000

0.000

.

AnxLev2(2)

.999

0.000

0.000

.

DepLev2

.875

DepLev2(1)

.983

0.988

0.333

2.930

DepLev2(2)

.664

0.843

0.391

1.817

SELev2(1)

.522

1.238

0.643

2.385

Constant

.999

3.200

None of the variables including anxiety, depression or self-esteem levels at 2 weeks
predicted retention at 8 weeks.

The following set of analyses (Tables 16 to 22) involved the progressive addition of
variables into equations looking for significant predictors of retention at 14 weeks.
The anxiety, depression and self-esteem scores were program entry scores.
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Table 23
Analysis No. 9 for Gender Predicting Retention at 14 Weeks
Step 1a

p

Exp(B)

95% C.I. for Exp(B)

Gender(1)

.425

1.248

0.724

Constant

.051

0.647

2.148

Gender did not predict retention at 14 weeks

Table 24
Analysis No. 10 for Gender and Age Group Predicting Retention at 14 Weeks
Step 1a

p

Exp(B)

95% C.I. for Exp(B)

Gender(1)

.328

1.318

0.758

2.293

Age group

.062

Age group (1)

.072

0.555

0.292

1.055

Age group (2)

.027

0.484

0.254

0.921

.903

0.966

(30-50 years)
Constant

The addition of age group to the equation indicated that the oldest age group (30-50
years) was significantly more likely to drop out of the program prior to 14 weeks (OR
= .484, 95% C.I. = .254/.921, p = .027).
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Table 25
Analysis No. 11 for Gender, Age Group and Primary Drug Predicting Retention at 14
Weeks
Step 1a

p

Exp(B)

95% C.I. for Exp(B)

Gender(1)

.328

1.318

0.758

2.293

Age Group

.062

Age Group(1)

.072

0.555

0.292

1.055

Age Group(2)

.027

0.484

0.254

0.921

Drug

.903

0.966

Drug(1)

.328

1.318

0.758

2.293

Drug(2)

.062

Drug(3)

.072

0.555

0.292

1.055

Constant

.027

0.484

0.254

0.921

(30-50 years)

The addition of primary drug to the equation showed that the oldest age group (30-50
years) were significantly more likely to drop out prior to 14 weeks (OR = .484, 95%
C.I. = .254/.921, p = .027).
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Table 26
Analysis No. 12 for Gender, Age Group, Primary Drug Type and Medication
Predicting Retention at 14 Weeks
Step 1a

p

Exp(B)

95% C.I. for Exp(B)

Gender(1)

.415

1.268

.716

2.245

Age Group

.161

Age Group(1)

.147

0.599

0.300

1.197

Age Group(2)

.068

0.533

0.271

1.048

Drug

.340

Drug(1)

.858

0.924

0.391

2.185

Drug(2)

.202

0.483

0.158

1.475

Drug(3)

.708

1.217

0.436

3.396

Medication(1)

.137

1.548

0.870

2.753

.633

0.775

(Any meds)
Constant

The addition of medication to the equation resulted in none of the variables predicting
retention at 14 weeks.
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Table 27
Analysis No. 13 for Gender, Age Group, Primary Drug Type, Medication and Anxiety
Level at Entry Predicting Retention at 14 Weeks
Step 1a

p

Exp(B)

95% C.I. for Exp(B)

Gender(1)

.448

1.253

.700

2.243

Age Group

.189

Age Group(1)

.184

.621

.308

1.254

Age Group(2)

.078

.541

.273

1.071

Drug

.324

Drug(1)

.880

.936

.394

2.224

Drug(2)

.220

.495

.161

1.521

Drug(3)

.626

1.296

.458

3.671

MedicationGroup(1) .115

1.595

.892

2.849

AnxLevEnt

.259

AnxLevEnt(1)

.118

2.993

.758

11.827

AnxLevEnt(2)

.102

3.052

.800

11.642

Constant

.115

.258

The addition of anxiety level to the equation resulted in no variable predicting
retention at 14 weeks.
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Table 28
Analysis No. 14 for Gender, Age Group, Primary Drug Type, Medication, Anxiety
and Depression Levels at Entry Predicting Retention at 14 Weeks
Step 1a

p

Exp(B)

95% C.I. for Exp(B)

Gender(1)

.437

1.262

.701

2.271

Age Group

.199

Age Group(1)

.199

.630

.312

1.275

Age Group(2)

.081

.543

.274

1.079

Drug

.394

Drug(1)

.979

.988

.413

2.365

Drug(2)

.321

.561

.179

1.760

Drug(3)

.540

1.390

.485

3.985

MedicationGroup(1) .079

1.699

.941

3.066

AnxLevEnt

.188

AnxLevEnt(1)

.069

3.899

.901

16.862

AnxLevEnt(2)

.092

3.190

.828

12.293

DepLevEnt

.463

DepLevEnt(1)

.231

.577

.234

1.420

DepLevEnt(2)

.857

.940

.479

1.843

Constant

.089

.229

The addition of depression level to the equation resulted in no variable predicting
retention at 14 weeks.
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Table 29
Analysis No. 15 for Gender, Age Group, Primary Drug Type, Medication, Anxiety,
Depression and Self-Esteem Levels at Entry Predicting Retention at 14 Weeks
Step 1a

p

Exp(B)

95% C.I. for Exp(B)

Gender(1)

.450

1.257

.694

2.276

Age Group

.291

Age Group(1)

.243

.654

.321

1.334

Age Group(2)

.131

.585

.291

1.174

Drug

.401

Drug(1)

.966

1.019

.422

2.460

Drug(2)

.362

.585

.185

1.853

Drug(3)

.487

1.456

.505

4.203

MedicationGroup(1) .077

1.709

.944

3.097

AnxLevEnt

.242

AnxLevEnt(1)

.094

3.594

.805

16.050

AnxLevEnt(2)

.118

2.993

.757

11.837

DepLevEnt

.723

DepLevEnt(1)

.709

.829

.310

2.217

DepLevEnt(2)

.652

1.181

.573

2.433

SELevEnt

.166

SELevEnt(1)

.635

2.227

.082

60.495

SELevEnt(2)

.059

1.899

.975

3.699

Constant

.029

.131

The addition of self-esteem level at entry to the equation resulted in no variable
predicting retention at 14 weeks.
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Table 30
Analysis No. 16 for Gender, Age Group, Primary Drug Type, Medication, Anxiety,
Depression and Self-Esteem Levels at 2 Weeks Predicting Retention at 14 Weeks
Step 1a

p

Exp(B)

95% C.I. for Exp(B)

Gender(1)

.369

1.320

0.721

2.419

Age Group

.143

Age Group(1)

.080

0.524

0.255

1.079

Age Group(2)

.088

0.537

0.263

1.097

Drug

.353

Drug(1)

.578

0.771

0.309

1.926

Drug(2)

.137

0.414

0.130

1.324

Drug(3)

.989

1.008

0.342

2.971

Medication Group(1)

.051

1.825

0.996

3.342

AnxLev2

.592

AnxLev2(1)

.780

0.660

0.036

12.208

AnxLev2(2)

.615

0.476

0.026

8.564

DepLev2

.437

DepLev2(1)

.244

0.564

0.215

1.480

DepLev2(2)

.828

0.925

0.460

1.860

SELev2(1)

.975

1.010

0.557

1.832

Constant

.709

1.811

The variables of gender, age group, primary drug type, medication, anxiety,
depression or self-esteem levels at 2 weeks did not predict retention at 14 weeks.
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Table 31
Analysis No. 17 for Gender, Age Group, Primary Drug Type, Medication, Anxiety,
Depression and Self-Esteem Levels at 8 Weeks Predicting Retention at 14 Weeks
Step 1a

p

Exp(B)

95% C.I. for Exp(B)

Gender(1)

.296

1.490

0.706

3.146

Age Group

.039

Age Group(1)

.887

0.931

0.344

2.515

Age Group(2)

.032

0.388

0.163

0.923

(30-50 years)
Drug

.281

Drug(1)

.680

1.255

0.426

3.694

Drug(2)

.393

0.557

0.145

2.136

Drug(3)

.373

1.823

0.486

6.828

Medication Group(1)

.028

2.252

1.094

4.638

(Any medication)
AnxLev2

.511

AnxLev2(1)

1.000

.000

.000

.

AnxLev2(2)

1.000

.000

.000

.

DepLev2

.682

DepLev2(1)

.383

.570

.161

2.014

DepLev2(2)

.515

.672

.203

2.225

SELev2(1)

.993

.996

.384

2.581

Constant

1.000

7.198E8

The highest age group (30-50 years) was significantly more likely to drop out prior to
14 weeks (OR = .388, 95% C.I. = .163/.923, p = .032), and the group taking
medication were more likely retained at 14 weeks (OR = 2.252, 95% C.I. =
1.094/4.638, p = .028).

Following an analysis of the various category variables, it was decided to adjust two
of the variables (Primary Drug & Anxiety Level) and re-run the previous analyses
involving all independent variables predicting retention at 8 weeks and 14 weeks,
(Analyses 18 – 22).
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The 2 variables adjusted for Analyses 18 - 22, were:
1) Primary Drug: Amphetamines =1; Opiates, Alcohol & Cannabis (Depressants) = 2.
2) Anxiety Level: Low Anxiety (0- 24) = 1; and Medium/High Anxiety (25 – 72) = 2.

Analysis 18 examined variables predicting attrition and retention 8 weeks after
treatment entry. The Dependent Variable (DV) was retention in treatment at 8 weeks,
and Independent Variables (IV) were gender, age group, medication use, primary drug
of abuse; and depression, anxiety and self-esteem levels measured at treatment entry.
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Table 32
Analysis No. 18 Retention at 8 Weeks with Entry Level Scores
Variable
Gender

OR

95% CI

p

1.127

.601/2.114

0.709

(depressants: opiates, 0.789

.423/1.471

0.456

0.832

.437/1.582

0.575

(males)

Gender 1 (female)
Drug
Drug 1

(amphetamines)

alcohol & cannabis)
Medication (none)
Medication 1 (any)
Age

(17 - 23 years)

Age 1

(24 - 29 years)

0.583

.280/1.211

0.148

Age 2

(30 - 50 years)

1.367

.636/2.940

0.424

0.817

.376/1.774

0.609

Depression level (medium)

1.284

.465/3.544

0.630

Depression level (high)

3.725

1.534/9.047

0.004

Self-Esteem level (medium)

0.661

.036/12.211

0.781

Self-Esteem level (high)

1.983

.966/4.070

0.062

Anxiety level (low)
Anxiety level (medium/high)
Depression level (low)

Self-Esteem level (low)

There was one significant variable predicting 8 week retention with treatment entry
depression, anxiety and self-esteem scores. The group with high entry levels of
depression were 3.725 times more likely retained at 8 weeks; (OR = 3.725, CI =
1.534/9.047, P = 0.004).

Analysis No. 19 examined variables predicting attrition and retention 8 weeks after
treatment entry. The Dependent Variable (DV) was retention in treatment at 8 weeks,
and Independent Variables (IV) were age group, gender, medication use, primary drug
of abuse; and depression, anxiety and self-esteem levels measured at 2 weeks after
treatment entry.
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Table 33
Analysis No. 19 Retention at 8 Weeks with 2-Week Scores
Variable
Gender

OR

95% CI

p

1.039

0.504/1.982

.908

(depressants: opiates, 0.622

0.326/1.189

.151

0.936

0.489/1.795

.843

(males)

Gender 1 (female)
Drug
Drug 1

(amphetamines)

alcohol & cannabis)
Medication (none)
Medication 1 (any)
Age

(17 - 23 years)

Age 1

(24 - 29 years)

0.620

0.297/1.293

.203

Age 2

(30 - 50 years)

1.592

0.701/3.614

.266

1.332

0.626/2.835

.457

Depression level (medium)

1.055

0.359/3.101

.923

Depression level (high)

0.874

0.409/1.868

.728

1.290

0.677/2.459

.439

Anxiety level (low)
Anxiety level (medium/high)
Depression level (low)

Self-Esteem level (medium)
Self-Esteem level (high)

There was no significant variable predicting 8- week retention in the seventh analysis:

Analysis No. 20 examined variables predicting attrition and retention 14 weeks after
treatment entry. The Dependent Variable (DV) was retention in treatment at 14
weeks, and Independent Variables (IV) were age group, gender, medication use,
primary drug of abuse; and depression, anxiety and self-esteem levels measured at
treatment entry.
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Table 34
Analysis No. 20 Retention at 14 Weeks with Entry Scores
Variable
Gender

OR

95% CI

p

0.816

0.458/1.455

.491

(depressants: opiates, 1.050

0.595/1.852

.867

1.571

0.877/2.814

.129

(males)

Gender 1 (female)
Drug
Drug 1

(amphetamines)

alcohol & cannabis)
Medication (none)
Medication 1 (any)
Age

(17 - 23 years)

Age 1

(24 - 29 years)

0.573

0.292/1.125

.106

Age 2

(30 - 50 years)

0.522

0.266/1.024

.059

1.283

0.642/2.564

.481

Depression level (medium)

0.833

0.316/2.192

.711

Depression level (high)

1.262

0.621/2.564

.520

1.967

1.019/3.797

.044

Anxiety level (low)
Anxiety level (medium/high)
Depression level (low)

Self-Esteem level (medium)
Self-Esteem level (high)

There was one significant variable predicting retention at 14 weeks. The high selfesteem 2 group were1.967 times more likely retained in treatment at 14 weeks
compared to the low self-esteem group, (OR = 1.967; 95% CI = 1.019/3.797; P =
.044). The oldest age group (30-50 years) were less likely retained in treatment at 14
weeks compared to the youngest group; (OR = 0.522; 95% CI = .266/1.024; P =
.059), however this result was not significant.

Analysis 21 examined variables predicting attrition and retention 14 weeks after
treatment entry. The Dependent Variable (DV) was retention in treatment at 14
weeks, and Independent Variables (IV) were age group, gender, medication use,
primary drug of abuse; and depression, anxiety and self-esteem levels measured 2
weeks after treatment entry.
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Table 35
Analysis No. 21 Retention at 14 Weeks with 2-Week Scores
Variable
Gender

OR

95% CI

p

0.749

0.416/1.349

0.336

(depressants: opiates, 1.033

0.583/1.832

0.912

1.673

0.928/3.015

0.087

(male)

Gender 1 (female)
Drug
Drug 1

(amphetamines)

alcohol & cannabis)
Medication (none)
Medication 1 (any)
Age

(17 - 23 years)

Age 1

(24 - 29 years)

0.497

0.250/.989

0.047

Age 2

(30 - 50 years)

0.502

0.251/1.004

0.051

1.354

0.691/2.653

0.377

Depression level (medium)

0.591

0.228/1.533

0.280

Depression level (high)

0.968

0.489/1.917

0.926

1.104

0.617/1.976

0.740

Anxiety level (low)
Anxiety level (medium/high)
Depression level (low)

Self-Esteem level (medium)
Self-Esteem level (high)

There was one significant variable predicting retention at 14 weeks when including 2
week depression, anxiety and self-esteem scores. The middle age group (24 – 29
years) were less likely retained in treatment at 14 weeks compared to the youngest
group (17-24 years); (OR = 0.497; 95% CI = .250/0.989; P =.047). The oldest age
group (30 - 50 years) were less likely retained in treatment at 14 weeks compared to
the youngest group (17-24 years); (OR = 0.502; 95% CI = .251/1.004; P =.051),
however this result just failed to reach significance.
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Analysis 22 examined variables predicting attrition and retention 14 weeks after
treatment entry. The Dependent Variable (DV) was retention in treatment at 14
weeks, and the Independent Variables (IV) were age group, gender, medication use,
primary drug of abuse; and depression, anxiety and self-esteem levels measured at 8
weeks after treatment entry.

Table 36
Analysis No. 22 Retention at 14 Weeks with 8-Week Scores
Variable
Gender

OR

95% CI

p

0.680

0.329/1.402

0.296

(depressants: opiates, 1.221

0.599/2.490

0.583

2.137

1.054/4.333

0.035

(males)

Gender 1 (female)
Drug
Drug 1

(amphetamines)

alcohol & cannabis)
Medication (none)
Medication 1 (any)
Age

(17 - 23 years)

Age 1

(24 - 29 years)

0.716

0.283/1.810

0.480

Age 2

(30 - 50 years)

0.324

0.283/1.810

0.009

1.775

0.672/4.688

0.247

Depression level (medium)

0.611

0.178/2.099

0.434

Depression level (high)

0.790

0.248/2.516

0.691

1.127

0.444/2.860

0.801

Anxiety level (low)
Anxiety level (medium/high)
Depression level (low)

Self-Esteem level (medium)
Self-Esteem level (high)

There were two significant variables predicting retention at 14 weeks in this analysis.
The medication group was 2.317 times more likely retained at 14 weeks than the nonmedication group; (OR = 2.137, 95% CI = 1.054/4.333; P = .035).The oldest age
group (30-50 years) were less likely retained at 14 weeks compared to the youngest
group (18 – 24 years); (OR = 0.324; 95% CI = .283/1.810; P = 0.009).
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Table 37
Summary of Significant Results:
(Variables predicting retention & attrition when all variables included in equations)
Analysis

Significant

Odds

Significant

Odds

Number

Variables

Ratio

Variable

Ratio

P <.05

> 1.0

P <.05

< 1.0

More

Less

likely

likely

8 week Retention 1
Entry scores 1

2 Week scores 1

7

H Anx (49-72)

6.024

H Dep (27-60)

3.517

Nil

8

Nil

Nil

Entry scores 1

15

Nil

Nil

2 week scores 1

16

Nil

Nil

8 week scores 1

17

Medicating

2.252

Age (30-50) 0.388

2 indicates Analysis Analysis

Significant

Odds

Significant

OddsR

(# 6 - 10) with 2 #

Variables

Ratio

Variable

atio

adjusted variables

P <.05

> 1.0

P <.05

14 Week Retention 1

< 1.0

More

Less

likely

likely

8 week Retention 2
Entry scores 2

18

H Dep (27-60)

2 week scores 2

19

Nil

Entry scores 2

20

S/E (High)

2 week scores 2

21

Nil

8 week scores 2

22

Medicating

3.725

Nil
Nil

14 Week Retention 2
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1.967

Nil
Age (24-29) 0.497

2.137

Age (30-50) 0.324
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Summary of Stage 1 Binary Logistic Regression Results

The initial 5 binary logistic regression analyses involving all independent variables
(analyses Nos. 7, 8, 15, 16 & 17) are discussed first; followed by a discussion of the
results of the second set of 5 analyses (analyses Nos. 18, 19, 20, 21 & 22) after two of
the independent variables were adjusted.

Analyses 7 & 8:
Analysis 7 indicated that 8 week retention was significantly predicted by clients with
high levels of anxiety and high levels of depression at treatment entry. Interestingly,
there were no variables predicting attrition by 8 weeks.
Analysis 8 indicated that no variables, including levels of anxiety, depression and
self-esteem at 2 weeks were significant for predicting retention or attrition at 8 weeks.

Analyses 15 – 17:
No variables predicted 14 week retention or attrition when using the anxiety,
depression and self-esteem level scores at entry (Analysis 15).
No variables predicted 14 week retention or attrition when using the anxiety,
depression and self-esteem level scores at 2 weeks (Analysis 16).
Retention at 14 weeks was predicted by clients taking medication when including the
8 week anxiety, depression and self-esteem scores (Analysis 17). The oldest group of
clients (30 – 50 years) were significantly less likely retained at 14 weeks when the 8
week psychopathology scores were included in the analysis.

Analyses 18 – 22:
Analyses 18 - 22 were undertaken after two independent variables had been adjusted.
These adjustments involved the collapsing of the initial 4 primary drug categories into
2 categories; i.e.

either depressants

(opiates, alcohol

and

cannabis), or

amphetamines/methamphetamines. The second adjustment was the collapsing of the
initial three levels of anxiety scores into two levels only; i.e. low levels of anxiety, or
medium & high levels of anxiety.
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Following these two variable adjustments, 8 week retention was only predicted by
high levels of depression at entry (Analysis 18).
When measuring depression, anxiety and self-esteem scores at 2 weeks, no variables
predicted retention or attrition at 8 weeks (Analysis 19).
14 week retention was predicted by clients with high levels of self-esteem at entry
(Analysis 20).
When incorporating the 2 week depression, anxiety and self-esteem scores into the
equation, no variables predicted 14 week retention, but the middle age group (24 – 29
years) were significantly less likely retained (Analysis 21).
When incorporating the 8 week anxiety, depression and self-esteem scores into the
equation, the medicating clients were significantly more likely retained, and the oldest
age group were less likely retained in treatment at 14 weeks (Analysis 22).

Stage 1 Discussion
The significant findings of the stage 1 analyses were as follows. Gender did
not have a significant influence on treatment retention or attrition at either 8-weeks or
14-weeks after program entry. Client age group predicted treatment attrition at 14weeks, but not in the expected direction of higher levels of attrition with younger
clients. Elevated depression and anxiety at entry scores predicted 8 week treatment
retention. Clients prescribed various psychoactive medications for mental health
problems were more likely to be retained in treatment at 14 weeks. The following
section will summarise the retention and attrition findings for each of the independent
variables analysed in the first stage of this study.

Gender and Treatment Entry
It is also important to note the gender disparity at treatment entry (150 males
or 64% of total 234 clients at entry, versus 84 females or 36%, representing a ratio of
male to female clients at entry of 2.8:1).The finding of a greater number of males
entering the substance abuse treatment program is common, and Greenfield, Brooks,
Gordon, Green, Kropp, McHugh, Lincoln, Hien & Miele, (2007) report a large review
of women substance abuse clients in the United States of America (U.S.A.), and note
that women are much less likely to enter substance abuse treatment services compared
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to men, hence mixed-gender, U.S.A. substance abuse treatment services almost
always have less females compared to male clients. This finding of much less women
entering substance abuse treatment services than males is not limited to U.S.A.
substance abuse treatment programs. Swift, Copeland & Hall (1996) report an
analysis of Australian alcohol treatment services, and note that male to female ratios
of clients in treatment ranged from 3:1 to 10:1.
The higher ratios of men versus women in substance abuse treatment are
usually greater in residential services, and many researchers have commented that the
significantly reduced number of women entering residential treatment services is due
to family and child-rearing responsibilities of women clients, (Szuster, Rich, Chung &
Bisconer, 1996). The finding that the proportion of total male and female clients
entering the TC during the period of data collection was less than 3:1 is interesting
given that women were unable to enter the treatment program with their children from
2000, or soon after the initiation of data collection of this present study. Clearly,
factors other than the ability of women clients to enter treatment with their children
must account for the fact the program was attracting a relatively high proportion of
female clients.

Gender and Treatment Retention
During the period of data collection there were 150 males and 84 females who
formally entered the program, and 143 males and 82 females remained in the program
by 2 weeks, representing 95.3 % and 97.6% of the original sample respectively.
Frequency analyses indicated that 104 males and 59 females were retained in
treatment at 8 weeks, representing 69.3% and 70.2% of the original sample. When
measuring retention at 14 weeks, 100 clients (67 males and 33 females) remained in
treatment, representing 42.7% of the original sample of 234 clients, with 44.7 % of
the original 150 males, and 39.3% of the original 84 females. There were no
significant findings for effects of gender on treatment attrition or retention at either
the 2-week, 8-week or 14-week periods.
The first important finding of this study relative to gender and retention was
there were no significant differences between male and female retention rates at either
8 or 14 weeks after entry. This finding that females were not more likely to drop out
of treatment may reflect specific program processes and components the TC had
introduced to help retain females in treatment. Specific program components
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introduced by the TC to support female clients include that female clients were
always offered the choice of a female counsellor, and that there was an emphasis on
individual counselling rather than confrontational mixed-gender group therapy typical
of many TC’s. Women were also housed in separate living quarters with strict rules
about access to those quarters, and the agency provided gender-specific therapy
groups, parenting education, and access to specialist gender-specific services in the
community. These women-sensitive treatment components in residential services
have been previously reported as contributing to retention of females, and some of
these findings are summarised by Greenfield et al. (2007). These program factors may
have contributed towards female retention rates in this sample comparable with the
male clients; however other factors possibly influencing female retention will be
examined next.

Gender and Anxiety, Depression & Self-Esteem Scores at Treatment Entry
Previous research has indicated that females were more likely to enter
substance abuse treatment with higher levels of depression and lower levels of selfesteem, and that these women were more likely to drop out of substance abuse
treatment prematurely (Haller, Miles, & Dawson, 2002; Wilke, 2004).
Consistent with previous findings many of the females entering the TC
reported high rates of depression with 57 of the 84 females (68%) reporting clinical
levels of depression (27-60 range) as measured at entry by the CES-D. In comparison,
only 73 of the 150 males (49%) measured in this range at treatment entry. A higher
percentage (50%) of females (82) remained in this higher level of depression scores at
2 weeks after entry, compared to 47 of the 143 males (33%). By 8 weeks however,
gender differences had mostly disappeared with only 9 of 59 females (15%)
remaining in the high depression level, compared to 14 of the remaining 104 males
(13%). There was a steady drop in mean depression levels for both males and females
after treatment entry.
The finding of high depression level scores for both males and females
entering the TC replicates previous findings that it is common for clients to enter
residential treatment with relatively elevated scores of psychopathology, especially
depression. The fact that depression scores decreased quickly for many clients,
reinforces previous findings of many researchers who note that staff should be
cautious of making mental health diagnoses at treatment entry. The findings of this
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study replicate previous findings noting there is a decrease in depression scores for
many clients during the initial weeks following residential treatment entry and
initiating abstinence from substance use (Gossop, Marsden & Stewart, 2006).
Females in the sample did not report consistently lower levels of self-esteem
compared to males, and no females scored in the lowest self-esteem range at treatment
entry. When comparing the other self-esteem ranges, 94 of 150 males (63%) scored in
the medium self-esteem range at treatment entry, compared with 59 of 84 females
(70%) scoring in that range. 54 males (36%) scored in the highest level of self-esteem
at treatment entry, compared to 25 females (30%) scoring in the highest range.
By 2 weeks after treatment entry, no male clients scored in the lowest level of
self-esteem. By 8 weeks, 20 of 104 males (19%) reported medium levels of selfesteem, compared to 18 of 41 females (44%). 84 of 104 males (81%) scored in the
highest range of self-esteem, and 41 of 59 females (69%) also scored in this range.
After 14 weeks following treatment entry, only 6 males (9%) of the remaining 67
males, and 6 females (18%) of the remaining 33 females, were in the medium range
of self-esteem scores. The large majority of clients, 61 (91%) of the remaining 67
males were in the high range of self-esteem, and 27 (82%) of the remaining 33
females were also scoring in the high range of self-esteem.
The general increase in client self-esteem following residential treatment entry
reflects previous findings that self-esteem increases over treatment time for women
(Wilke 2004). However not all studies have reported a mean increase in self-esteem
scores during residential substance abuse treatment. Malcolm (2004) reports a study
of 305 homeless male substance abusers residing in a residential treatment facility
who were compared to a control sample receiving community-based treatment. Selfesteem scores did not show a major change over time for either group, and the mean
self-esteem score for both groups was slightly lower at immediate post-treatment (3
months), and at other time intervals following, than mean self-esteem scores at the
initiation of treatment. The author notes that for their sample of homeless males, selfesteem scores do not necessarily increase following decreased substance use.
There was no consistent major gender difference in self-esteem scores at
treatment entry for the sample, and this contradicts the findings of many other reports
stating that women are more likely to enter treatment with lower self-esteem.
Women’s self-esteem scores in this sample also increased over time similar to
increases in the men’s self-esteem scores.
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It is possible that the analysis and tools used to measure psychopathology in
this sample were insufficient to capture important patterns of psychiatric problems
and score change over time. It is therefore possible those women entering treatment
with greater depression scores also reported lower self-esteem scores than males
entering treatment with similar depression scores, and those women were less likely
to improve in depression and self-esteem over time. Edokpolo, James, Kearns,
Campbell, and Smyth (2010) report the results of a relatively small sample of
adolescents (65 males and 23 females) seeking substance abuse treatment. They note
that although the sample was small, the females reported much higher internalising
and externalising psychiatric scores than the males, and that the female comorbidity
patterns were often more complex than for the males in the sample. The authors note
that distinct comorbidity patterns within clients may account for different etiological
roles in the development of substance abuse problems, and consequently have
different treatment requirements and outcomes. The authors suggest that increasing
self-esteem may be more important for female clients than male clients during
substance abuse treatment.

Retention and Depression, Anxiety & Self-Esteem Scores
The first set of analyses utilising all independent variables (Analyses 18-22),
indicated that clients with medium and high levels of anxiety at treatment entry were
significantly more likely to be retained at 8 weeks. Clients with high levels of
depression at treatment entry were significantly more likely retained at 8 weeks in
both sets of analyses. Clients with high levels of self-esteem at treatment entry were
significantly more likely to be retained at 14 weeks in both sets of analyses (18-27).
The finding that clients entering the program with high levels of depression and
anxiety were more likely retained at 8 weeks was not expected. As previously
described, the majority of previous retention research findings have reported that
client mental health problems are more likely to predict treatment attrition.
It is possible that specific program factors may account for the finding that
clients with high levels of anxiety and depression were more likely to remain in the
program. Two specific program factors that have been previously noted as important
in affecting client retention is the relative number of allocated clients per counsellor
(Hser, Joshi, Maglione, Chou, & Anglin, 2001), and the level of counsellor
qualifications (Simpson, Joe, Rowan-Szal, & Greener, 1997).
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Although weekly client counselling forms a major part of most residential
treatment programs, Simpson et al. (1997) report that the effectiveness of counselling
on retaining substance abusing clients in treatment has primarily been demonstrated
only for qualified and experienced counsellors. Hser et al., (2001) undertook an
extensive analysis of retention involving 26,047 clients in 87 Los Angeles County
substance treatment programs, and noted that staff qualifications was an important
program factor helping predict retention in most programs. Despite these findings of
the importance of counsellor qualifications influencing client retention in substance
abuse treatment services, Meier, Donmall & Heller (2004) report a survey of 326
English and Welsh specialist drug treatment services, and report that only 17% of
these services provided counselling by accredited counsellors. The survey collected
responses from 58 services who were identified as residential treatment services, and
51 (88%) of these services provided individual counselling to clients, but few of the
counselling staff had any formal counselling qualifications.
This author is not aware of Australian statistics regarding the percentage of
residential treatment staff having formal counselling qualifications, but during the
time of data collection it was not required that residential substance abuse treatment
programs employ accredited counselling staff. Despite the lack of state requirements,
the majority of the Palmerston Farm counselling staff were graduate trained, and the
program employed at least one post-graduate clinical psychologist in a senior clinical
role throughout most of the data collection period. Employing senior clinical staff
with counsellor supervisory responsibilities also enabled the training of clinical
psychology trainees in the clinical program during those years. The counsellor:client
ratio during this period was approximately 4 to 5 clients per counsellor, reflecting a
low counsellor client load when compared to most U.S.A. and U.K. residential
treatment programs. Hser et al. (2001) note that a low number of clients per
counsellor can help prevent counsellor burn out, and predicts improved client
retention rates.
The post-graduate clinicians in the TC program were usually allocated to
clients of the same gender who had been identified at treatment entry with elevated
anxiety and depression scores. The interventions with the higher risk clients were
primarily cognitive behavioural therapy (CBT) in orientation, and tailored to suit
individual client needs. The relatively low caseloads of the counselling staff,
mandatory weekly supervision of counsellors by senior experienced clinicians, and
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the use of post-graduate trained clinical staff in residential substance abuse treatment
programs for client counselling is uncommon in residential substance abuse treatment
settings. These specific program factors may have influenced the findings, and may
therefore also restrict generalisation of the findings.
Another specific program factor that may have influenced the retention finding
of this study was the program began allowing client use of prescribed psychoactive
medications for various mental health disorders from 1999, and during the following
6 year period of data collection. The effectiveness of psychoactive medication use in
improving client substance abuse treatment retention in Australian TC or other
residential substance abuse programs has not been widely reported or researched.
Other specific program factors that may have influenced reported retention
findings in this study include that the program reduced the availability of packaged
food, drinks with high sugar content, tobacco, and music and television use. A strong
emphasis was also placed on the importance of utilising appropriate social support
within the community, healthy nutrition, exercise, recreation, appropriate sleep
patterns, and engagement in meaningful work activities. The work activities involved
training in various tool uses (e.g. welding, fabrication and construction), tractor and
other machinery use, property maintenance, and the commercial production of
accredited organic fruit and vegetables. Various work activities involving both staff
and clients were scheduled on most week-day mornings from 7am-11 am.
Although there is no research indicating the effectiveness of work-related
program structure factors contributing to client retention, experienced senior program
staff believed meaningful work activities and the mandatory introduction of healthier
lifestyle factors helped reduce client anxiety and mood symptoms, and thereby
encouraged program retention. These regular activities could be described as a form
of “behavioural activation” (Martell, Dimidjian & Herman-Dunn, 2010), which has
been shown to be an effective intervention for depression. The engagement of client
interest in improving various aspects of their lifestyle may have also had beneficial
effects in engaging client trust. Improved trust and therapeutic alliance between staff
and clients has been shown by several studies (Corrigan & Bogner, 2007; Curran et
al., 2009) to positively affect treatment retention rates.
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Age and Treatment Retention
The older group of clients (30-50 year olds) were more likely to leave
treatment before 14 weeks when including the depression, anxiety and self-esteem test
scores at 8 weeks in the first set of analyses. The second set of analyses indicated that
the 24-29 year old group were more likely to leave before 14 weeks compared to the
younger group of 17-24 year olds when including the 2-week depression, anxiety and
self-esteem test scores. The 30-50 year old group were more likely to leave treatment
before 14 weeks compared to the younger group of 17-24 year old group when
including the 8-week test scores.
The finding that the youngest group of clients were less likely to drop out of
treatment is not supported by the majority of research findings regarding residential
treatment retention. Most previous retention studies have reported that older clients
are better retained in substance abuse treatment (Joe, Simpson & Broome, 1998), and
state that this is a reflection of older persons usually having greater motivation to
change their substance use patterns. Brecht, Greenwell, and Anglin (2005) analysed
10 years of data for methamphetamine treatment admissions to Californian services,
and reported that clients with limited education, more severe drug use, injecting drug
use patterns, and being younger were more likely to drop out of treatment.
One possible reason why the younger client group was better retained in this
treatment sample is that their drug use history was generally shorter and less severe
than older clients. Numerous studies report that clients with a longer and more severe
substance use history usually have a history of relapsing and treatment failure,
(Williams & Chang, 2000).This current study was unable to include these factors in
the analyses as drug use severity and drug-using history were not recorded in the
programme’s archived data set.
It also remains possible that specific program factors relating to the TC may
account for the finding that the younger clients were more likely retained in treatment.
One distinct part of the Palmerston Farm TC was the incorporation of a variety of
work activities within the therapeutic program. These mandatory work activities
included community meal preparation, general property maintenance, automated
irrigation maintenance, a tree and plant nursery, care of a range of animals, and the
commercial production of a wide range of certified bio-organic foods. Many of the
younger clients in the program reported little past engagement in paid employment
work, and consequently possessed limited employment work skills. Most clients were
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generally keen to engage in the program’s work-related activities; however it is
possible that older clients with more experience in the paid work force were more
reluctant to engage in unpaid work for relatively long periods within the program.
During the latter part of this data collection period, the program had initiated
the accreditation process of having various work skill acquisition components of the
program formally recognised. This initiative was especially welcomed by the younger
clients who often reported having no formal training or work qualifications. The
program also trained interested residents in bulk food purchasing, meal planning, food
preparation, kitchen and personal hygiene, food storage, cooking and related kitchen
responsibilities, and accreditation for these skills was also being sought.
Although differences in client work engagement attitudes were not measured,
it is possible that greater work engagement positively affected client mood, anxiety
and self-esteem levels, such that work was indirectly influencing the retention of
younger clients. The influence of therapeutic involvement in residential programs
positively affecting retention of young adolescent clients has been previously reported
by Hawke, Hennen, and Gallione (2005). The authors note that therapeutic
involvement facilitates the recovery process and also manifests as improved trust and
positive rapport with program staff.

Primary Drug and Retention
There was no significant finding for primary drug of abuse although clients
who had indicated opiates as their primary drug of abuse were more likely to leave
treatment prior to 8 weeks. This finding was unexpected as previous research had
indicated greater difficulty for programs retaining methamphetamine-abusing clients,
rather than clients who had nominated other substances as their primary drug of use
(Maglione, Chao & Anglin, 2000). Considerable research has been published
regarding the complexities of treatment for methamphetamine users in the last decade.
This includes research findings indicating that methamphetamine use often results in
extended withdrawal periods, and is associated with a range of mental health
problems affecting treatment retention (Dyer & Cruikshank, 2005; and GlasnerEdwards, Mooney, Marinelli-Casey, Hillhouse, Ang, & Rawson, 2008). Other studies
have failed to find a significant effect for methamphetamine influencing substance
abuse retention (Hammerbacher & Lyvers, 2006), or post-treatment 1 year treatment
outcomes, (Luchansky, Krupski, & Stark, 2007).
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Table 3 indicates that only 25.8% of the opiate–abusing clients in this sample
were in the youngest age group (17-23 years), compared to 38.6% of
methamphetamine users being in that age group. The mean age of the opiate group
(28 years) was older than the mean age of the methamphetamine-using group (25
years). As previously noted older clients were more likely to leave treatment before
14 weeks. Another possible reason that young methamphetamine clients were retained
in treatment is that the program allowed continued client use of prescribed
psychoactive medications. Many of the methamphetamine using clients entered the
treatment program with high levels of anxiety and depression scores, and although
these measures tended to quickly decrease in the large majority of clients, senior
clinical staff believed that prescribed medications appeared to support some clients
through the initial stages of the treatment program.

Psychoactive Medication Use and Retention
Both sets of analyses indicated that the clients who had been prescribed
psychoactive medications were significantly more likely retained in treatment at 14
weeks when analysed with 8 week depression, anxiety and self-esteem scores. High
self-esteem and medication use were the only significant predictors of 14 week
retention. The finding that the client group taking psychoactive medication were more
likely retained at 14 weeks appears to validate the decision by this agency to change
its existing policies in 1999, and begin accepting clients to their residential service
who had been prescribed various psychoactive medications.
This author is not aware of previous published research regarding prescribed
psychoactive medication use affecting substance use residential treatment retention.
The fact that pharmacotherapy may help improve the retention of clients has been
noted however, and in particular Haller and Miles (2004) note that many women who
enter residential treatment with high levels of psychopathology may be helped to
remain by the availability of prescribed psychoactive medications. This author is not
aware of information indicating the frequency of prescribed medication use in
Australian residential substance abuse treatment centres. Knudsen, Ducharme, and
Roman (2007) report the results of a large survey of medication use in 403 privately
funded and 363 publically-funded treatment services in the USA. They note that less
than half of these services (49.3%) allow the use of SSRI medication, and only 21.2%
allowed Naltrexone use. They report a tendency for 12-step based programs to not
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allow medication use, and for medication use to be adopted by those services with
detoxification facilities, access to physicians, and who employ a high proportion of
Master’s-level counselling staff.
From early 1999, the Palmerston Farm TC began accepting clients prescribed
various psychoactive medications. The rapid increase in the availability of
methamphetamines in Western Australia (W.A.) from the late 1990’s appeared to
coincide with a large increase in young persons applying for entry to the service who
had been diagnosed with various mental health problems including psychoses. The
influx of large numbers of young clients with methamphetamine-abuse problems
having concurrent mental health difficulties and prescribed psychoactive medications,
resulted in a significant increase of tension within the existing clinical team. The
majority

of

the

program’s

counselling

staff

had

no

experience

with

methamphetamine-using clients, and believed the TC should not admit clients
prescribed psychoactive medications. Program management persevered with the
policies allowing medicating clients, and consistent with findings reported by
Knudsen et al. (2007), were able to support existing clinical staff by increasing the
number of clinical psychologists on the team, and forging closer ties with the local
public mental health services. Within two years of changing client medication policies
and increasing the number of post-graduate trained clinical staff, the average length of
client stay in the TC more than doubled to 100+ days, and remained above 100 days
for the following years of data collection. This significant increase in the client
average length of stay occurred despite the increased complexity of client
presentations.
The finding in this study that clients prescribed psychoactive medications were
significantly more likely to be retained in the program at 14 weeks, suggests client use
of prescribed psychoactive medications may be helpful in achieving improved client
retention rates in AOD residential treatment services. Few treatment retention studies
have reported if clients are prescribed medications, and counselling qualifications and
other program factors may be confounding factors in this study, so the usefulness of
client medication usefulness requires further investigation from other client retention
studies where possible effects of this variable on retention have been analysed.
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Stage 2
The second stage of this study involved qualitative analysis of focus group findings
where the primary quantitative findings from stage one of this study were presented to
Chief Executive Officers, Program Managers and senior clinicians from major
Australian and New Zealand therapeutic communities for feedback and general
discussion.

Stage 2 Aims
The primary aim of the stage 2 focus group was to explore the implementation value
of the Stage one findings. The focus group presented the Stage one findings to the
focus group participants who were all well experienced with TCs. Feedback about the
stage one findings was sought, followed by an exploration of barriers and possible
solutions to implementing knowledge of identified stage one variables influencing
treatment retention and attrition in therapeutic community treatment programs. The
aims of the second stage were framed as the following three questions to participants:

What are the participant’s thoughts or reactions to the Stage 1 findings?
Can participants identify any barriers and possible solutions to including knowledge
of the identified Stage 1 client factors in this study that predict attrition in TCs?
What other factors may be likely influencing client attrition and retention within TCs?

Stage 2 Method
The second research stage was qualitative research involving a single focus group
with senior representatives of leading Australian and New Zealand TCs. The analysis
was undertaken using a thematic analysis method whereby major themes were
identified from analysis of the focus group transcript. Sub-themes of the major themes
were identified and explored with reference to the relevant published literature.

Participants
The Program Managers and senior clinicians of various non-government
agencies providing AOD therapeutic community (TC) services within Australia and
New Zealand were invited to participate in a focus group session lasting
approximately one hour (Appendix A).The nominated participants were attending the
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2011 Australasian Therapeutic Communities National Conference held in Fremantle,
Western Australia and were invited to participate in the focus group by this author.
There were five male participants and four female participants representing
therapeutic community services based in urban Australian cities, a New Zealand city,
and one remote Australian community.

Stage 2 Procedure
Once participants had agreed to take part in the focus group, they were
provided with an information letter (Appendix B) outlining the nature of the study.
All participants were required to sign a consent form prior to participating in the focus
group, and were provided with the opportunity to clarify any issues regarding the
nature of the research. They were informed of their right to withdraw from the
research at any stage without any adverse consequences. Focus group attendees were
advised that the discussion was recorded by audio recording, and were assured that all
comments remained confidential and non-identifiable, and that only the primary
researcher would transcribe the taped session.
Initially the researcher described the proposed primary research goal of
exploring hypothesised relationships between factors believed to contribute to
residential treatment retention and attrition. The focus group sought to elicit
participant responses to the stage one research findings, explore barriers and solutions
to incorporating knowledge of the identified variables affecting client attrition and
retention, and discuss alternate methods of retaining clients at higher risk of attrition.
Each dependent variable from the initial stage of the study was discussed with the
participants who provided feedback about their perception of the relevance of those
variables in affecting TC treatment retention and attrition. The majority of participants
generally agreed with the findings presented, and these responses were further
explored for possible reasons why some of these findings differed from previously
reported findings in the literature. Participants described what they believed were
other important factors affecting client treatment attrition and retention in their
respective therapeutic communities. Various solutions and barriers to client retention
problems were also explored.
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Stage 2 Analysis
The audio recording was transcribed verbatim and analysed using thematic analysis
(Braun & Clarke, 2006) to determine themes relevant to participant perceptions and
comments regarding the research findings. The thematic analysis procedure involved
careful multiple readings of the transcription, before identification and grouping of
participant comments into major identified themes, and sub-sets of the major themes.

Identified Themes and Sub-Themes
After thorough analyses of the data set a decision was made to code the data collected
from the focus group into two broad themes, named “client factors” and “program
factors’. These two themes were constructed to further sort the data-set statements
regarding the various variables hypothesised to influence client retention and attrition.
The two major themes included all variables that were the focus of the first stage of
the study, but also included other factors believed by many of the participants to be at
least equally important for improving or at least influencing client retention.

The various variables from Stage 1 that were presented to the group for discussion
have been listed as sub-themes of a broad theme labelled “client factors”. The subtheme of client motivation in this group was not included in the initial stage of the
study, but recognised by all participants as a major dynamic client factor influencing
treatment retention, and has been included under the primary theme of client factors.
All participants noted that various non-client factors were very important influences
on client retention and attrition. These factors have been collected under the broad
theme called “program factors”. The two major themes identified of “client factors”
and “program factors”, and the respective sub-themes of each are listed in Table 14.
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Stage 2 Results
Table 38
Major Themes of Client & Program Factors, and Sub-Themes
Client Factors

Program Factors

Age

TC Model Practices

Gender

TC Medication Policy

Primary Drug

TC Client Dynamics

Mental Health

TC Staff

Motivation

The themes identified by the thematic analysis were reduced to two major themes of
client factors and program factors. The previous stage 1 independent variables were
identified as sub-themes of the client factors; and the sub-themes of the program
factors were identified by the focus group participants as factors they believed were
also relevant to client retention and attrition. These sub-themes of both the major
themes of client and program factors will be discussed in turn with reference to the
relevant research literature.

Stage 2 Discussion
Major Theme - Client Factors
Client Age
The finding that older clients were more likely to leave treatment early compared to
younger clients received minimal feedback from the group. One service manager
mentioned that most of their clients would fit into the young age category (18-24
years) described by the current study. Several managers stated that their service did
not experience problems retaining young clients because they adapted their TC
program years ago to better retain the younger clients coming to their service.
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Most participants agreed with a statement by one manager that services can retain
younger persons in the TC, however they noted that younger clients are more prone to
boredom and it was necessary to maintain a well-structured program for them.

“You can retain them in the TC, so long as you keep them busy”.

The manager of the agency servicing remote aboriginal communities noted that they
mostly have older clients (50+) in their service, and that although younger clients may
enter the service, their retention is dependent on there being others of a similar age.

”Our age group is all the older age group (50+). But we do get younger ones
in, however we find that those younger ones… that if there is not already an
age group around their age group, then that young person will not stay.”

Possible client attrition due to a population comprised of significantly different age
groups within a particular substance abuse program has not been a focus noted in the
treatment retention research literature. It is possible this is because there has been a
tendency in the last two decades in particular for the establishment of adolescentspecific and alcohol-specific services. Despite the possibility of retention problems
due to client age differences, the majority of participants agreed that some positive
outcomes are gained by mixing clients of different ages within a treatment service.

“We have got four houses on our campus, and originally our place was
organised where you started at House # 1, then went to # 2, then # 3, and
House # 4 was the women’s house. So one of the things we did was actually
mix the houses, so it’s not rocket science, so you have older people looking
after the younger people, and that has made a significant difference to our
(client) retention”.

This importance of older and more senior clients helping younger clients orientate to
the rules and processes within the TC so the younger clients are more likely to remain
in treatment was described by a New Zealand program manager who stated:
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“If you don’t have older people there, you are kind of expecting the people to
lick it off the grass or something, to kind of get the understanding of what is
going on.”

“And they wonder why it is so unhealthy, and why it isn’t working” (Stated in
context of without there being any older residents around to instruct newer
and younger residents).

The exchange below was between two group participants discussing the use of older
residents to visit an off-site pre-admission house to help orientate prospective TC
residents:

“In our pre-admission house we take some of the older residents to stay the
night.”
“That’s a good idea.”
“It’s also good for the older residents too.”

In describing the components of a generic TC program De Leon (2000) states in
reference to the importance of residents helping each other : “All members of the
community are expected to be role models – roommates; older and younger residents;
junior, senior, and directional staff. TCs require these multiple role models to
maintain the integrity of the community and assure the spread of social learning
effects” (De Leon, 2000; p. 383). This statement reflects participants’ belief that client
retention is likely to improve when there is mixing of different aged clients within a
spirit of mutual help fostered by clients and staff in the TC.

Following the discussion of client age effects on treatment retention, the next
hypothesised retention variable that was discussed was client gender differences.

Client Gender
The finding of no significant gender differences in treatment retention was
accepted and agreed by the majority of participants. Most participants agreed that
women are a minority in most of their TC services, and that they often arrive with
more severe mental health issues. Several participants mentioned that they had
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introduced specific program factors into the services in recent decades to better retain
and support women. These factors included separate rooms and houses, genderspecific group work, and same-sex counsellors where possible.

“Women come into treatment a lot more damaged than men. It’s easier for
men to get into treatment. By the time a woman gets there, they are a lot more
damaged. Learning how to work with that, and in a way with those separate
rooms and different places.”

An important issue that emerged during the discussion was the provision of
gender-specific housing. One manager of an Australian residential agency servicing
rural and remote aboriginal communities mentioned that it was almost impossible to
be referred or to retain aboriginal women in that service until they could offer womenonly accommodation. For example:

“We actually had to set up a specific women’s house because of the cultural
factors around that. We found that if we have more than one or two women in
(the service), that they will always stay, and they will stay the full term; but if
we have less women in, the less they will stay around.”

A large review of published literature from 1975 to 2005 of substance abuse treatment
entry, retention and outcomes for women by Greenfield, Brooks, Gordon, Green,
Kropp, McHugh, Lincoln, Hien, and Miele (2007) noted that women were generally
less likely than men to engage with any specific substance abuse treatment service,
especially residential services. The authors note that women were more likely than
men to engage with mental health services for their substance abuse problems. They
also note that women with trauma histories, including sexual and physical assault and
abuse may be less attracted to mixed-gender treatment services.

“We found we had to keep space for women, not to fill the house with men. We
had to keep so many beds, and make a woman friendly area.”
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The importance of gender specific areas and housing seems to be even more critical in
the rural and remote TC programs servicing Aboriginal populations as captured by the
following statement of a service manager:

“People in the community won’t refer to us until they spoke to me about
identifying a specific house for women. And we did that and we assured them
there would never be a male within that environment. Once we guaranteed
that, our numbers went up by 700% within the first six months.”

Baird (2008) examined the literature regarding various barriers for women entering
substance abuse treatment and noted there was considerable evidence that many
women do not enter residential treatment in particular because women are generally
the primary childcare providers. The Greenfield at al., (2007) review also noted that
there were more barriers for women than men to initially enter substance abuse
treatment, however once they had entered treatment their retention and outcomes were
often reported as better than the males. Another important point raised in the
discussion was the comment that many women may leave treatment early because of
family and other responsibilities.

“Yes females accessing that service and again, that ideal of women
completing the program, there are many variables around that you have to
take into account. But they were more stable in the long-term, and accessed
the transitional after care program with the one-on-one program in the home
environment, and stuff like that. They accessed that more than the men did,
and used that support system well.”

“…because a lot of women chose not to complete 6 months because they were
going back to families. It didn’t necessarily mean that treatment was a failure;
it meant that there were personal and other responsibilities. What we found in
the same research was that whilst we got fewer women through to completion,
the women in the longitudinal studies did better”.

This statement supports previous findings regarding the difficulty of retaining
some female clients in residential treatment. The Greenfield, et al., (2007) review
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noted that several previous studies reported that treatment retention was influenced by
the number of children the female client had (the more children, the less likely to be
retained), and whether the female client received sufficient support from their spouse
or family influenced their retention in treatment. The next hypothesised treatment
retention variable that was discussed was the clients reported primary drug of abuse.

Client Primary Drug
The majority of participants answered “No” to the question of whether they
believed that the primary drug of abuse helped predict client attrition. Upon further
exploration of this response it became apparent that most of the TCs had adapted their
treatment programs during the last decade to better retain the younger clients coming
to their treatment services with amphetamine/methamphetamine problems. This
indicates that retaining the particular client group of methamphetamine users had
previously been more difficult, and this was captured by the following statement by
one of the New Zealand program managers:

“What (X) was saying before, about 12 years ago when methamphetamine
first came to New Zealand we had to learn how to work differently. Right so
that was keeping it really busy for the younger ones. That was a really
important part, so we did change, and that has helped retain them… how we
learned to work with methamphetamines.”

The key point noted by this manager was their service was able to improve retention
of young methamphetamine clients in their TC by changing their program to keep the
younger clients sufficiently engaged and occupied. This is an important point because
it indicates that programs and treatment staff are able to positively and successfully
respond to particular demands and needs to improve the retention of young persons.

“We struggle the most with their retention...opiates.”

“I think that’s true of Opioid users who tend to leave our service program
earlier, and are less disaffected by mental health issues including anxiety and
depression, and they have been well serviced over a period of time.”
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Several participants noted that they now struggle to retain opiate users in TC
treatment, and one manager of a service that accepted clients prescribed Methadone (a
synthetic opiate), noted that they tended to lose many younger male clients
prematurely from their program because they wanted to return to using illicit opiates
in the community:

“What we kind of concluded, and remember that Methadone might be part of
it, was that this group of men who were the youngest kids, were keen to get off
(Methadone), and “get on” (start using opiates again). This was a group of
men who were starting to get quite entrenched and possibly hadn’t finished
(using). Do you know what I mean?”

There was general agreement with the first stage finding of this study that
retaining opiate users in treatment was now more difficult than retaining
methamphetamine users; however no reasons were offered to explain this change. It
was apparent that some TCs had successfully responded to the growth of a generally
younger population of methamphetamine users in their services by introducing
program adaptations designed to improve retention of this group by keeping these
clients occupied, motivated, optimistic, and better engaged with staff and more senior
residents. It is not possible from the analyses undertaken here however to determine if
these various program adaptations to better hold methamphetamine users in treatment,
have inadvertently influenced the attrition rates of clients with opiate use problems.

Client Mental Health
The finding that clients reporting high levels of depression and anxiety at
admission were more likely to be retained at 8 weeks was accepted by the majority of
participants who agreed that these clients are not more likely to leave treatment
prematurely now. Several managers commented that many of the clients entering
treatment with elevated mood and anxiety scores are more likely to remain in
treatment than clients without these mental health problems. Two managers noted:

“We found that the clients that reported the highest psychological distress at
admission appeared to be the people that stayed longer, and they were also
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the people that tended to engage themselves in as many of the services, both
medically and externally that our program had to offer.”

“I know the more disaffected they are by mental health, and drugs and
alcohol, the longer they stay here, that’s true.”

One manager noted that retention of clients with mental health problems was
influenced by the perception of other clients, and therefore the presence of others with
mental health problems makes it easier for those persons to remain in TC treatment.

“I can see that when we have a community when there’s a higher level of
dysfunction, dysfunctional people are more likely to stay”

The large analysis of 58 published studies examining the effects of mental health
problems and substance abuse treatment retention and attrition undertaken by Meier
and Barrowclough (2009) noted that elevated depression scores did not consistently
predict retention or attrition. The authors note that several studies reported that more
severe depression predicted retention, whereas mild depression did not. They also
note that two studies suggested an interaction between service modality and retention,
in that depressed clients were more likely to remain in residential treatment
programmes, but not necessarily more likely to remain in outpatient or methadone
programmes.
This finding that the more severely depressed clients are likely to remain in
residential treatment is consistent with the report of the service manager quoted above
who suggests the more depressed clients may be more likely to remain in treatment to
better access medical and other services offered by the agency. Another TC manager
noted that their service provided a range of mental health medical services that they
believe better enabled their service to hold on to clients with a variety of serious
mental health issues:

“So we have had psychiatrists for about 20 years, and a GP on site, and a
nurse for the last 20 odd years (a mental health nurse). So they are tested at
the beginning and medicated if they need to be, and that is continuous, so the
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high end users do tend to stay, and those people do include poly-substance,
including methamphetamines, and they are young as you said.”

This statement reflects the suggestion by Knudsen, Ducharme, and Roman (2007) that
services that implement evidence-based policies allowing client use of prescribed
psychoactive medications with the support of supplementary psychiatric and mental
health services may be better able to service and retain client groups with complex
mental health and substance abuse (comorbid) problems.

This pro-medication use statement by this program manager did arouse
substantial reactions from two others managers who disagreed with providing clients
with psychoactive medications to better support clients with mental health problems.
The two managers stated that they did not allow client use of medications because
they believed clients should be “drug free” to better enable appropriate assessment of
their mental health. Both of these managers noted that their programs operated with a
“drug-free” approach. Roman, Abraham, and Knudsen (2011) note that the use of
medications in treatment services is still strongly opposed by many programs
especially those services with a “12-step” and/or “drug free” approach.
The primary issue conveyed in this discussion was that most services had
adopted various measures in the last decade to better retain clients with mental health
issues. Some services did this by providing relevant medical and social services,
whereas other services sought alternative non-medication methods to support the
retention of these clients. The issue of differing beliefs and policies about client use of
medication is further discussed in the sub-theme discussion of medication use. The
fact that some clients react negatively to remaining in a service with many persons
having serious mental dysfunction was also mentioned during the discussion, as was
the importance of client motivation for seeking and remaining in treatment.

Client Motivation
The majority of participants agreed with one manager’s statement that client
motivation was the most important factor predicting client entry and retention in
substance abuse treatment. It was agreed by all participants that a client’s motivation
for treatment can be affected by many factors, and that motivation changes over time.
Specific and common motivators mentioned by participants in regard to this included
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the motivation not to lose a partner or children, the desire not to go to prison, the
desire to find suitable work, to find stable accommodation, and the motivation to
generally obtain a better quality of life.

“Our only predictor (of client retention) is motivation. Reasons for coming to
treatment. It’s the only one that we can establish.”
Motivation for entering and remaining in substance abuse treatment has been
the focus of much theory and research in recent decades. DeLeon, Melnick, and
Kressel (1997) describe the critical role of client motivation to enter and engage with
substance abuse treatment, and that treatment is believed to produce positive changes
in the client leading to engagement, reinforcement and retention in treatment.
Motivation was not included as one of the variables for study in the first stage of this
study however, and hence discussion of this factor will be restricted.
Residents enter substance abuse treatment with a range of internal and external
motivational factors, and some motivations are believed to be more important than
others in predicting treatment retention and outcomes. A recent paper by Klag, Creed,
and O’Callaghan (2010) describing the role of various types of motivation in 350
residents entering six Australian TCs is relevant to this point. The authors note the
important role of non-autonomous motivation, or extrinsic motivation in clients
seeking and entering substance abuse treatment. This type of motivation is described
as regulated by the demands of others or external factors, and that people act in a
certain way (e.g. enter treatment) to avoid negative consequences of continued
substance abuse. Klag et al., (2010) note however that externally regulated behaviours
are contingency-dependent, and show poor maintenance once the contingencies are
withdrawn. One example of this in the substance abuse treatment field is some clients
who enter treatment to avoid prison, and then return to substance abuse after the risk
of imprisonment (or other external motivator) has passed.
An earlier paper by Ryan, Plant, and O’Malley (1995) examining internal
versus external motivation in clients seeking outpatient treatment for alcohol abuse,
reported that clients high in internal and external motivation showed the best
engagement and retention in treatment. Clients high in internalised motivation also
showed good engagement and retention, whereas the clients low in internalised
motivation showed poor engagement and retention irrespective of the level of external
motivation. These results suggest that although residents enter treatment with a range
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of internal and external motivations of varying intensity, it is important that the person
engages with internal motivations for substance use cessation or improved control,
during and following treatment to increase their chances of enduring positive
outcomes.
Some TC’s have trialled the use of specific interventions to either directly or
indirectly enhance client motivation for the purpose of improving client TC retention.
Soyez, De Leon, Broekhaert, and Rossel (2006) describe a trial undertaken in four
Belgian TCs of a social network intervention for new clients. This intervention
involved showing new clients and their family and friends, a video to orientate them
to the TC, and an induction day with a following discussion with the TC staff.
Compared to a control group of clients, the clients receiving the intervention were
more likely to be retained in the TC and subsequent analysis revealed that the client’s
perceived social support and motivation were significant factors enhancing retention.
The manager of an agency servicing Aboriginal communities made a comment
regarding remote Aboriginal client motivation to access and remain in substance
abuse treatment. His comment reflects much of what has been stated in the research
literature about the role of motivation of clients with substance abuse persons of all
ages, genders, drug use patterns, mental health status, and from various cultures.

“There’s always a crisis in their life. There’s always a crisis motivation for
them coming into treatment at some point, whether it’s legal, whether it’s a
family situation, whether it’s a personal one, and depending on that force of
that motivation in their life at that moment, will dictate how long they will stay
when they are completing it for us.”

Client motivation will not only vary in motivation type and strength between
individuals, but may vary between cultural groups, and change over time. This has
important implications for TC clinical staff that need to understand and work with an
individual’s motivation for entering and remaining in treatment.
Despite cultural differences in client motivation for treatment and differences
in program structure and characteristics within different cultures, there is evidence
that very different substance abuse treatments are still effective. Moggi, Giovanoli,
Strik, Moos, and Moos (2007) describe an analysis of the relationship between
program characteristics, client substance use and psycho-social functioning at a oneTherapeutic Community Retention
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year follow-up in a comparison of Swiss and U.S.A. residential treatment programs.
The authors state that despite great differences in client characteristics, program
content and intervention focus, similar outcomes were obtained at the one-year
follow-up. The authors suggested that underlying processes of substance abuse
treatment may enable the generalisation of treatment outcomes across cultures, but
note that this was one small study that requiring further research.
The underlying processes affecting the outcome of client substance abuse
treatment such as client motivation are often referred to as “dynamic factors”
influencing client treatment retention and attrition. These dynamic client factors have
increasingly become recognised as significant factors predicting treatment attrition
and retention, and have become a major focus of study.
An analysis of factors associated with the retention of youth aged 13 – 19
years in various New Zealand residential and outpatient substance abuse treatment
programs undertaken by Schroder, Sellman, Frampton, and Deering (2009) reported
that a range of dynamic client characteristics and program variables were more likely
to predict treatment retention than fixed client characteristics such as gender, criminal
history, mental health status and primary drug problem. The more important dynamic
client factors found to be significant for treatment retention included having higher
internal motivation, greater external pressure to engage in treatment, and expectation
of positive treatment outcomes and general life outcomes. The study also noted two
significant program characteristics predicted retention of youth, and these were
involvement with set treatment goals, and positive relationships with staff.
The importance of client motivation and positive client-staff engagement as
predictors of retention rather than fixed client characteristic such as a client’s primary
drug was mentioned during the discussion with the focus group participants. After the
initial focus of discussion regarding the Stage 1 significant findings, the focus of the
discussion shifted to participants discussing various “program factors” that they
believed played an important role in determining client retention and attrition. The
program factors identified by the participants are discussed in the following section.
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Major Theme - Program Factors

TC Model Practices
Therapeutic communities (TCs) offer a specific form of residential substance
abuse treatment with quite distinct program practices that has been described as
“community as method” (De Leon, 2000, p.92.). Although these various practices
may differ according to service philosophy, size and structure of the TC, and the
particular population they are serving, many of the practices are common to most
TCs. Some of these practices were noted by the focus group participants as important
for engagement with new residents and thereby promoting their retention in treatment.
All participants agreed with the usefulness of a “buddy system”, or similar
process within TCs whereby new residents are helped by another resident to orientate
to the community norms and expectations. This mentoring technique is very common
in TCs and always involves the assigning of a more experienced resident to help
support the new resident for the first few weeks after their entry to the community.

“A buddy system is very important.”

“Yet those first few days and first couple of weeks, of actually getting people
settled is more important than getting the medication stuff right I think.”

The buddy system was a technique all participants acknowledged as important for
helping to retain new residents because it facilitated their positive orientation to the
community, the therapeutic program, and the many rules and community practices.
Assigning a senior person as buddy or mentor who is more stabilised in treatment also
lessens the likelihood of the new person gravitating to residents who may be
ambivalent about treatment and therefore at an elevated risk of treatment attrition. The
process of guiding and supporting a more vulnerable new resident commonly
reinforces the older resident’s awareness of their own personal growth since being in
the community. The TC model notes the importance of residents learning from all
others in the community, especially those who have been there longer and progressed
along their treatment path, and are therefore more senior within the typical
hierarchical structure of residents within the TC community. Senior residents are
required to accept a range of increasing responsibilities within the whole community,
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especially the monitoring and supporting of more vulnerable new clients that occurs
within the buddy system.
There was agreement that the initial perceptions of a new resident entering the
community are very important, and that attempts to make these initial perceptions
positive is valuable in helping maintain their retention at this more vulnerable time.
One method mentioned for helping new residents feel welcome when they enter the
TC was having a welcoming ritual for them. One of the New Zealand TC services
described their welcoming process.

“It’s a cultural welcome where they actually have to come in and the whole
community meets them, and they say who they are. It’s just a lovely welcome.”

“I love the idea of having a welcoming committee. We looked at that and
thought how we could improve it.”

“We have started doing that, called a cultural welcome. So they use a
‘palfrey’ when they come in. It’s very important.”

“With singing, yes it’s traditional… Yes, it’s beautiful.”

Most TCs place importance on the person being welcomed to the community
and helping them develop a sense of trust and belonging with program staff and other
residents. De Leon (2000) describes the typical TC induction stage of treatment as
lasting 30 days, and notes that clients are at highest risk of attrition during this stage.
The TC buddy system and formal welcome are specific TC practices designed to help
the new person orientate to the TC program’s requirements, rules and practices. These
welcoming practices also play an important role in helping the new resident feel
valued and supported when they are in a period when they are most vulnerable to
treatment attrition.

Medication Policy
The provision of prescribed psychoactive medication to clients in TC
treatment elicited some strong and opposing views that reflect broader divisions about
this topic in substance abuse treatment centres of different modalities and treatment
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philosophies in the USA, Australia and New Zealand. Interestingly, the finding from
the first stage of this study that clients prescribed medications were more likely
retained at 14 weeks was not challenged by any participant, and most participants
acknowledged that medications can help support many people especially during the
early stages of treatment.
One issue raised by several participants regarding medication was whether
persons prescribed psychoactive medication whilst they were still using alcohol and
illicit substances, would have received an accurate diagnosis. A proponent of a “drugfree” TC stated their position.

“For some residents it can be more de-stabilising, because they are often
prescribed their medication when they are still using, so they’re whole
physiology is changing and a lot of residents who come through our
rehabilitation were having had regular doctors that have been readjusting
medication, or changing of medication, or in some cases there’s been overprescribing of medication. So in a sense it can almost work against some
residents, because we first try and find someone on a stable basis for them to
kind of work in the community, but we are also trying to find a stable basis of
what is the medication they should be on, and what dose.”

This perception above reflects the acknowledgement that it is very difficult for
a mental health professional to discriminate symptoms of some mental illnesses from
some symptoms of substance abuse. It is therefore common that clients who have
been abusing substances and have been in contact with medical professionals prior to
residential treatment entry will have been prescribed psychoactive medications for
mental health symptoms that may be primarily substance-induced. An advantage of
residential substance abuse treatment services is that staff can more reliably ensure
that the client’s drug use has ceased. Because most mental health symptoms of
substance abuse disappear or dissipate within the first few weeks of drug use
cessation, more discriminate mental health diagnoses can therefore be assessed.
Many TC and other residential substance abuse treatment services deny entry
to clients currently prescribed psychoactive medications because these services don’t
have medical or nursing staff that can monitor resident or dispense medications within
their facilities (De Leon, 2000). Many substance abuse treatment services also do not
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have easy access to external mental health professionals or medical services
experienced with undertaking mental health assessments of substance abusing clients.
This lack of integration between mental health and substance abuse services
remains problematic in many developed Western countries. Gil-Rivas & Grella
(2005) report the results of a survey of administrators and staff in 10 mental health
and 16 substance abuse programs in Los Angeles County in California, and note that
there remains significant variation of integration between mental health and substance
abuse services, and highly variable staff perceptions within both services of the levels
of integration of these two types of services.
The alternative viewpoint that there are advantages to client retention by
allowing persons to enter residential treatment who have already been prescribed
psychoactive medications, or who are prescribed medications soon after entry, was
captured by the following participant’s comment:

“That’s where I think sometimes it does help your cause, because one doesn’t
know whether it is the anti-anxiety (medication?). Because coming off
amphetamines they do suffer a lot of anxiety. There is a lot of symptoms here,
depression and anxiety that comes with amphetamines specifically, so it’s
really hard to know what’s going on, and retention is enhanced by giving them
something that lowers that uptight and depressive feeling so they are less
likely to leave”.

The above statements express the situation of many residential substance
abuse treatment services with respect to mental health assessment and comorbidity.
The case argued by one of the participants above is that client psychoactive
medication use can alleviate some common symptoms of substance use withdrawal,
such as heightened levels of anxiety and depression. In support of this position of
allowing medication, a large study of over 100 U.S.A. treatment services with war
veteran client populations reported that inpatient programs with more medication use
had lower attrition rates (Swindle, Phibbs, & Paradise, 1995).
Many TCs have adapted their previous drug-free policies during the last
decade by either allowing persons who have already been prescribed psychoactive
medications to enter their treatment programs, or by having persons assessed and
prescribed medications by trained mental health professionals within the service, or
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having new clients with mental health problems screened and assessed by local
medical practitioners or mental health professionals whom they regularly work with.

“Well yes because we have an MOU with the mental health service, and we
have a really tight relationship with them, and they talk about most things, so
they kind of know who we are and that has built up over years and years. We
have also got some staff co-located in the medical centre so they understand
what we do, and we understand what they do, so we consult quite a bit.”

However without close integration between the two services many
community-based medical professionals are unfamiliar with discriminating mental
health problems from substance-induced mental health symptoms, and symptom
changes during the course of substance withdrawal. The following statements by
several TC managers (mostly from services with drug-free policies), reflect this lack
of service integration. The perception of many TC staff and managers is that many
medical professionals inexperienced with working with TCs are over reliant on
prescribing psychoactive medications for client’s transient mental health symptoms.

“Every time you (we) get a new GP or you get a new Psychiatrist, you have to
go through an education process.”

“In many ways I feel empathy for the doctor, because trying to get a doctor
not to use his prescription pad is like asking an addict not to use.”
(Many laughs by TC managers who could relate to this common problem).

“But that is the challenge that we are talking about though isn’t it? Educating
what is different about someone being in a TC, to someone being held in the
community. A doctor is totally responsible for that person (in the
community).”

Many modern TC’s have either employed their own mental health professional
staff to counter this reliance on external professionals, or developed relationships with
their local medical general practitioners and mental health professionals to allow
improved exchange of information about mental health issues, substance abuse, and
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the common course of client mental health symptoms following substance use
cessation. These TC-medical relationships often take years to develop and changes in
TC professional staff and/or local medical and mental health staff can quickly result
in deterioration of the mutual understanding of each other’s professional work.
Collaboration between mental health and substance abuse treatment services
has often been problematic and divisive. A staff survey of Queensland mental health
and substance abuse treatment services reported that insufficient collaboration
between the services remained a major problem in dealing effectively with comorbid
clients (Kavanagh, Greenaway, Jenner, Saunders, White, Sorban, & Hamilton, 2000).
Although this survey of staff perceptions in mental health and substance abuse
treatment services was undertaken over a decade previously, many of the reported
problems of insufficient collaboration, mutual understanding and integration of these
two services have continued in many developed countries (Gil-Rivas & Grella, 2005).
One New Zealand TC service that did not allow psychoactive medication use
by clients mentioned they alternatively used a pre-admission house to help people
complete substance use withdrawal and better orientate to substance use cessation
before entering the TC. They stated that this pre-admission service had significantly
improved their residential retention rates by helping clients adapt to living without
substance use prior to going into the residential service. They believed this orientation
service helped persons cope with cessation of substance use and significantly
decreased the need for continuing use of any prescribed psychoactive medications.

TC Client Dynamics
Several managers stated they believed that retention of clients with mental
health problems especially was influenced by client dynamics with their TCs:

“I can see that when we have a community where there’s a higher level of
dysfunction, dysfunctional people are more likely to stay. Where there’s a
community of a high level of dysfunction, if I’ve got some life skills I might
only stay a few weeks and then get on with it. Whereas if there’s other people I
can relate to in the community, whether they be from the same criminal
background, or they seem to be of the same skill level as me, I’m more likely to
stay on.”
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An important point noted by this manager is that there can be a large variation
of client types in a TC at any particular time, and the “client mix” can effect attrition.
The increasing recognition of client mental health comorbidity especially in recent
decades led to the development of TCs that specialised in servicing that client group.
These “modified TCs” were developed because it became apparent that some standard
TC practices such as the more confrontational group work were unsuited for clients
with major mental health difficulties (De Leon, 2000). Other modified TCs have also
been developed to better retain clients by servicing distinct substance abusing
population needs, including the needs of women, prison populations, adolescents,
homeless men and women, HIV positive and AIDS clients, and methadone clients.
These specialised or modified TCs are usually only available in areas situated nearby
large urban populations where there is more likely to be sufficient demand for
specialised residential treatment services.
In smaller cities, and rural and remote areas, there is usually insufficient
demand to justify funding specialised residential programs or TCs designed
exclusively for particular substance abusing populations. In those cases, residential
and TC staff must integrate more heterogeneous client populations and most treatment
services rely on program rules, policies and support services to lessen the likelihood
of negative client dynamics developing that may result in treatment attrition. Most of
the residential substance abuse treatment services and TCs in Western Australia are
non-specialised programs containing a wide variety of clients.
Typical TC program policies designed to better retain heterogeneous client
populations include specific group work for sub-populations within the TC, the use of
the “buddy” system, and more considered allocation of counselling staff to meet the
needs of particular clients. Other means of servicing specific client treatment needs
within non-specialised services include the provision of supplementary services
including mental health and medical services, child care, vocational training, activities
to meet parole requirements, debt reduction services, gambling treatment, family
therapy, relationship counselling and mediation, and post-treatment housing
requirements. Despite the variety of specific services offered by these generic TCs
and residential treatment programs, many clients nevertheless leave treatment early
and this attrition is often attributed to dynamic factors within the client population.
Common dynamic factors within TCs affecting client attrition are often
triggered by clients breaching standard TC rules. These rules almost always include
Therapeutic Community Retention

112

client prohibitions of alcohol or other drug use, sexual relations between clients,
interpersonal violence, vandalism, theft, and threats to clients and/or staff. Client
dynamics within a TC quickly become negative when clients rule breaches are not
quickly admitted or exposed. “Hidden” rule breaches commonly leads to a culture of
secrecy, divisions within the client community, and commonly culminates in multiple
client attrition. TC staff therefore emphasise the need for all clients to contribute to
the “safety of the community” by early admission of rule breaches, and enforcement
of the rules. This culture of openness and respect for rules is critical to the therapeutic
health of the TC, but is usually a challenge to the norms and beliefs of clients from
illicit drug-using cultures and/or prisons where keeping secrets, violence and use of
threats is very common.
New residents arriving to the TC very soon after substance abuse withdrawal
are at high risk of attrition during the first few weeks of their orientation process, and
it’s not uncommon for new residents to influence others to break the community rules
and leave the TC with them. This negative influence of a new client can have a
powerful effect on the dynamics of the community; so many TC programs have
developed various procedures to decrease this risk. The allocation of a more
experienced older client or “buddy” to help orientate and support new clients
perceived as higher risk, and early engagement by senior staff with new clients are
some examples of TC procedures aimed at supporting new clients through the initial
stage after treatment entry. One participant described how it was common in New
Zealand TCs to lessen this risk of early attrition of new clients by having an extended
pre-admission phase for potential clients:

“I was quite gob-smacked coming from New Zealand to Australia, at how (I
mean at one level I thought it was exciting and challenging), but how different
it was how we get residents in. Because if you listen to New Zealand people
here, they are going to talk about their clients who arrive quite civil. But they
are actually working with them way before they get there, so they have
separate assessment staff that are working with them from day one, and they
have got these visits to the TC.”

“And we have prior admission to the residential treatment; they actually come
in and have lunch at the house…. Then they get to see what the community is
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like, and how it runs. So they might have two meals, and once they are in the
pre-admission house, and they go over to the main house three times each
week with all the others, so they get to see.”

TC Staff
The importance of TC staff in helping settle new clients in the therapeutic
community was also noted, and all participants agreed with the statement below that
client engagement was strongly influenced by early contact with clinical staff. The
second statement below notes that this staff contact can also occur effectively in
group format:

“We found one of the predictors of retention in the early stages of treatment
was staff contact.”

“At out TC that is not necessarily that easy because we don’t actually have
single case management with the client. So what we did was we started two
induction groups per week for the people in the first month where they just
came as a group and met with staff to ask questions about the TC or whatever,
and we made sure that the personal carers or senior residents were attending
to them all the time explaining the program. But senior staff engagement is
predictive really of retention.”

The importance of counselling staff positively engaging with new clients has
been previously noted in the substance abuse treatment outcome and retention
literature, (De-Weert-Van Oene, Schippers, DeJong, & Schrivers, 2001; and Barber,
Luborsky, Gallop, Crits-Cristoph, Frank, Weiss, Thase, Connelly, Gladis, &
Siqueland, 2001). More recently, Palmer, Murphy, Piselli, and Ball (2009) undertook
a qualitative survey of client and outpatient treatment staff perspectives after clients
had dropped out of treatment. The findings noted that treatment retention was
positively affected by the development of an early therapeutic alliance between staff
and clients.
The number and type of professional and non-professional staff within TCs
may vary greatly according to the size of the service, the client population, the amount
and source of funding, the location of the TC, and the agency’s guiding philosophy of
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substance abuse and recovery. De Leon (2000) describes the evolution of substance
abuse treatment from the 1960’s when almost all TC staff were persons who
previously had substance abuse problems, commonly called recovered persons or
persons in recovery, compared to more recent TCs that employ many professional
staff without substance abuse histories. Modern large TCs commonly employ
psychologists, social workers, psychotherapists, teachers, physicians, nurses, lawyers,
accountants and other professionally trained staff, but it remains common to also
include some recovered persons in the TC staff profile who often serve as powerful
role models to residents.
In substance abuse outpatient services, mental health and human services in
the general public domain, the relationship between the client and the professional is
viewed as the primary therapeutic element. Within the TC however, the client’s
relationship to “the peer community” is viewed as the essential therapeutic element,
hence the term “community as method” is often used to describe the TC treatment
process. TC Staff serve important roles as facilitators, guides, role models, and
managers of this client/peer community relationship.
Most TC programs are structured so that the client community plays a major
role of influencing the client, however most TC and other residential services also rely
heavily on staff counsellors. Meier, Donmall, and Heller (2004) reported the results of
a national survey of 326 drug specialist services in England and Wales and stated that
individual counselling was undertaken in 78% of residential services. The counselling
provided in residential services was generally provided on a weekly basis, but only
provided by accredited counselling staff in 62% of residential services. Staff without
counselling certification provided individual counselling sessions in the majority of
all drug services surveyed (74%), and in only 16% of services was counselling
provided exclusively by qualified staff.
Hser, Joshi, Maglione, Chou, and Anglin (2001) report the results of a survey
of 87 programs in Los Angeles County and note that individual counselling was
provided in 78.5% of residential programs, which is remarkably similar to the U.K.
survey results reported above by Meier et al. (2004). Hser et al. (2001) note that the
lower average caseload of clients (mean = 8 clients per counsellor) by residential
counsellors was one of the few significant factors predicting client retention.
Although the authors do not mention the percentage of residential counsellors with
formal counselling qualifications, it can be presumed that counselling has an
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important role in client retention due to the reported counsellor/client caseload
retention effects.
Although weekly client counselling forms a major part of most residential
treatment programs, Simpson et al. (1997) report that the effectiveness of counselling
on retaining substance abusing clients in treatment has been demonstrated only for
qualified and experienced counsellors. Hser et al. (2001) undertook an extensive
analysis of retention involving 26,047 clients in 87 Los Angeles County substance
treatment programs, and noted that staff qualifications was an important program
factor helping predict retention in most residential programs. This researcher is not
aware of Australian statistics regarding the proportion of counselling provision by
graduate or post-graduate qualified staff within TC and other residential drug
treatment services, but there is no obvious reason to suspect major differences from
the U.K. or U.S.A. survey results reported.

Overall Discussion
It should be first noted that a relatively high proportion of the clients in this
therapeutic community service were retained in treatment at 2 weeks and 8 weeks
during the period of data collection. The high proportion of clients still retained at 2
weeks especially was believed by senior clinical staff to be a consequence of the
stringent entry criteria at this particular TC that had been designed to exclude clients
at unacceptably high risk of early attrition and consequent program disruption. The
TC program entry criteria required the majority of clients entering the program during
the period of data analysis to produce at least two consecutive urinalysis samples
showing no alcohol or illicit drug use during the one or two weeks immediately prior
to program entry. Most pre-entry clients were engaged in outpatient counselling or
other forms of support, and had received information about the TC program rules,
structure and expectations. It was believed that this mandatory withdrawal, pre-entry
support and orientation prior to TC entry greatly reduced the high rates of early
attrition that are commonly noted in the research literature. It should therefore be
noted that the various variables significantly predicting 8-week and 14-week client
retention and attrition findings of this TC sample may have limited generalisability to
other TCs with significantly different pre-admission requirements and procedures.
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The following sections will summarise the stage one findings for each of the
independent variables analysed in conjunction with the input from participants in the
second stage of the study, and compare the findings with the published literature.

Gender and Treatment Retention
The finding of no significant differences between male and female retention
rates at either 8 or 14 weeks after treatment entry was unexpected as it was not
consistent with the literature. As previously noted this result may reflect specific
program processes and components the TC introduced to help retain females in
treatment. Many of the participants in the second stage of the study also mentioned
that their TCs had introduced gender-specific program factors such as separate
housing and gender-specific group work, and stated that they believed these program
factors exerted important influence on both the entry and retention of female clients at
their TC services. It is therefore probable that these gender-sensitive program factors
that existed within the TC contributed to better access and retention of female clients.
Previous research has also indicated that females were more likely to enter
substance abuse treatment with higher levels of depression and lower levels of selfesteem, and that these women were more likely to drop out of substance abuse
treatment prematurely (Haller, Miles, & Dawson, 2002; Wilke, 2004). The Greenfield
et al. (2007) review note that women have often reported a higher incidence of cooccurring mood and anxiety disorders, and therefore many women may perceive the
lack of psychiatric services within substance abuse treatment services as a significant
barrier to entry. It is therefore possible that the TC program studied was attractive to
many female clients entering with high levels of depression because for the initial
years of the data collection period it was the only Western Australian residential
substance abuse treatment service admitting clients prescribed psychoactive
medications for diagnosed mental health disorders.
Previous reported findings that women are more likely to have higher levels of
depression at treatment entry was also supported by this study where 68% of women
compared to 48% of men entered treatment with depression levels in the clinical
range. Several second stage participants noted that many women entered their
programs with significantly higher need for health and mental health services than
male clients, and believed that the provision of these services contributed to higher
female TC access and retention rates.
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There was no consistent major gender difference in self-esteem scores at
treatment entry for the sample, and this contradicts the findings of many other reports
stating that women are more likely to enter treatment with lower self-esteem.
Women’s self-esteem scores in this sample also increased over time similar to
increases in the men’s self-esteem scores. There was no significant gender difference
in treatment entry anxiety scores, and these also tended to reduce for both men and
women over time.

Age and Treatment Retention
The stage one finding that the youngest group of clients (17-24 year olds)
were less likely to drop out of treatment by the 14 week stage was also unexpected
and not consistent with the majority of research regarding treatment retention. Many
previous retention studies have reported that older clients are more easily retained in
substance abuse treatment (Joe, Simpson, & Broome, 1998; Brecht, Greenwell, &
Anglin, 2005). However, this finding that younger clients were more likely retained
was accepted by many of the second stage participants who noted that their programs
had adapted content and style in recent years to better retain the increasing number of
young persons with alcohol and methamphetamine problems accessing their
programs. It is therefore probable that the introduction of specific program factors to
better retain young persons may help account for the finding. As noted previously, the
TC program in this study had a compulsory work and training component included in
the program structure that was believed by senior staff to have powerful positive
psychological effects on client mood, anxiety and self-esteem, and thereby helping to
retain younger clients. However it also remains possible that younger clients had a
short and less severe substance use history, including less history of treatment failure,
and were therefore less susceptible to treatment attrition.

Primary Drug and Retention
There was no significant finding for primary drug of abuse affecting retention
which was also unexpected given most previous research has indicated programs had
greater difficulty retaining methamphetamine-abusing clients. However the fact that
more recent published research (Hammerbacher & Lyvers, 2006; Luchansky,
Krupski, & Stark, 2007) has not found that methamphetamine-using clients are more
likely to leave treatment prematurely and relapse, suggests that some treatment
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programs may have adapted their programs to better retain these clients. Several of
the second stage participants noted that in more recent years they experienced more
difficulty retaining the generally older opioid-using clients in TC treatment compared
to the commonly younger group of methamphetamine-using client group. As noted
previously, the older clients were more likely to leave treatment before 14 weeks in
this program. Another possible reason the methamphetamine-using clients were more
successfully retained in treatment was the program allowed prescribed psychoactive
medication use, especially given many methamphetamine-using clients entered the
program with high levels of anxiety and depression.

Depression, Anxiety & Self-Esteem Scores and Retention
An important finding of the first stage analysis was that clients with medium
and high levels of anxiety, and high levels of depression at entry were significantly
more likely to be retained at 8 weeks, and clients with high levels of self-esteem at
treatment entry were significantly more likely to be retained at 14 weeks. The finding
that high levels of anxiety and depression predicted retention was unexpected given
the majority of previous research findings report that client mental health problems
predict treatment attrition. This finding was accepted by most of the second stage
participants however, several of whom noted it was common for the clients of their
services with the most mental health problems to remain longer in treatment,
especially when they were supported to access various health services they required.
Although not discussed with the second stage participants, it is possible that
the low caseloads of the relatively highly qualified counsellors in the TC program
could account for the retention of clients with mental health difficulties. Both low
client caseload of counsellors, and having well qualified professional counsellors have
been noted in the literature as having a positive effect on client retention (Hser, Joshi,
Maglione, Chou & Anglin, 2001; Simpson, Joe, Rowan-Szal, & Greener, 1997).
Another specific program factor that may have influenced the retention of clients with
elevated depression and anxiety scores was that the program allowed client use of
prescribed psychoactive medications for various mental health disorders.

Psychoactive Medication Use and Retention
The stage one findings also reported that clients prescribed psychoactive
medications were significantly more likely retained in treatment at 14 weeks. This
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finding that pharmacotherapy may help improve client retention of clients supports
previous research reported by Haller and Miles (2004), however very few treatment
retention studies have reported whether clients are taking prescribed psychoactive
medications, and this appears to be an important finding requiring further research. It
should be noted that the use of psychoactive medications by clients within Australian
TCs is relatively new with the majority of Australian TC treatment programs only
allowing client medication use within the last ten to fifteen years. Although there was
acceptance of the useful role of psychoactive medications by most of the second stage
participants, there was a divergence in participant responses about how client
medication use should be adopted by programs. Two participants noted that their
programs did not allow clients to enter their services with medications because of
concerns about the validity of mental health assessments when persons were still
using substances prior to treatment entry. Another obstacle to client medication use
noted by several participants was their limited reliable access to health professionals
familiar with their programs and their understanding of substance abuse and recovery.
Several participants described difficulties establishing enduring professional
relationships with local medical and psychiatric services, and believed medical
services rarely understood TC treatment processes, and tended to over-prescribe to
substance abusing clients. These participants described extended TC pre-entry
assessment practices they claimed allowed their staff to support new clients and more
reliably discriminate on-going mental health problems from temporary substance–
induced mental health difficulties. The consensus view of participants however, was
the recognition that many clients are vulnerable to attrition in the initial weeks after
treatment admission, and various forms of support are beneficial in retaining those
persons within the TC, whether that be various forms of peer support, psychiatric
medication use, or extended orientation and support prior to TC entry.

Limitations of This Study
There are several limitations of this study. These include that measures of
various program factors, and client dynamic variables such as client motivation for
treatment were not included in the agency’s database. Other fixed client variables
such as years of drug use, drug use severity, previous AOD treatment, education
levels, qualifications, and whether the client was court-mandated for treatment, were
also not included in the database. These factors therefore could not be included in the
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initial quantitative analysis, and it remains possible that some of these factors may be
significant indicators of treatment attrition. Another limitation of the qualitative
analysis is that limited resources did not enable a second coder to analyse the focus
group data. A further limitation of this study is that the data was collected from only
one TC and therefore findings may not be generalisable to other TC programs within
Australia or overseas. This TC had several unusual features of operation that were
unique within Australasian TCs at that time. These uncommon features included a
mandatory farm work program including work skills training and the commercial
cultivation of organic vegetables. The program was also unusual in that there was no
incorporation of 12-step philosophy in the therapeutic program. There was an
alternate emphasis placed on exposing clients to various recreational pursuits, the
teaching of various stress management techniques, and instruction in mindfulness and
other meditation practices. The program also employed at least one Masters level
clinical psychologist on the clinical staff for most of the data collection period.
Despite the limitations of the database utilised, and possible limitations in the
generalisability of the findings from this study to other TCs, this study remains an
important contribution to the Australian AOD treatment retention research literature.
In particular, the repeat measures of mood, anxiety and self-esteem undertaken
throughout the program, indicated that clients with significant mental health
difficulties were able to be held in treatment without major modifications to the
treatment program. The study also indicated that the large majority of clients reported
significant improvement in mood scores during the initial weeks of treatment,
irrespective of whether clients were taking prescribed psychoactive medications.

Conclusion
The analysis of the second stage responses indicated there was general
agreement with the first stage findings, even though the findings were obtained from a
single Western Australian TC program, and collected from a client population from
between six to eleven years ago. The general agreement with the first stage retention
findings by the focus group participants may reflect that current TC client populations
have maintained a high proportion of young persons with methamphetamine-use
problems. The retention outcomes obtained from a decade old data sample appear to
have remained relevant because the data were collected from the beginning of the
rapid increase in methamphetamine-use in the Australasian region that has continued
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to have a major influence on the profile of client treatment populations. Most of the
second stage participants reported that the shift in dominant client population profile
from opioid to methamphetamine use since 2000 has required major modifications of
practices and policies within most Australian and New Zealand TCs since then. The
retention and attrition findings of this study were not consistent with most of the
existing literature from the U.S. and U.K. studies that have been published. However
a major strength of this current study is that the data were collected from an
Australian treatment population over a period of six years from within a single
therapeutic community program. A limiting factor of the current study was that many
client variables were not included in the data archive, and that the therapeutic
community may have had significant differences from other TCs. Various program
factors not included in the analyses may have influenced client attrition and retention
rates, and therefore the findings of this study may be less generalisable to other
residential substance abuse treatment services.
Several second stage participants described alternate solutions that their
Australian and New Zealand treatment programs had developed to overcome some of
the identified client retention risk factors including the problems of retaining women,
young persons, methamphetamine users, and persons with complex mental health
needs. Some participants described non-medicating means of safely supporting clients
during the early stages of TC treatment, including the early stages when mental health
diagnoses remain uncertain and clients are experiencing major discomfort amidst
withdrawal and change in physical and mental health symptoms. The innovative
solutions designed for the purpose of retaining higher risk clients described by TC
managers in the second stage of this study, may help explain why therapeutic
communities have remained an important and enduring component of substance abuse
treatment services within Australia and New Zealand. In support of this statement,
Tinworth (2012) reports that the Australasian Therapeutic Community Association
(ATCA) currently has 38 members who run 66 TCs in Australia and New Zealand.
Although this study is an analysis of client treatment outcomes from only one
Western Australian therapeutic community, the findings from this program combined
with the input from other Australian and New Zealand TC managers, suggest that TCs
remain a robust substance abuse treatment model capable of adapting their programs
to meet complex client treatment needs, changing drug use patterns, and changing
drug-using populations within the wider community.
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APPENDIX A
LETTER OF INTRODUCTION TO AGENCY DIRECTORS/CEO’S

DATE
ADDRESS

Dear………,

My name is Mark Porter and I am undertaking a Doctor of Psychology degree
at Edith Cowan University. As part of my degree I am conducting a research
study designed to assess various client factors that may contribute to client
attrition from Alcohol and Other Drug (AOD) residential treatment services. As
you are aware treatment attrition from AOD residential services very often
predicts relapse to substance abuse.
Early recognition of factors that predict client attrition may allow residential
treatment services to instigate interventions designed to counter treatment
attrition, and thus increase residential treatment success rates.

The first stage of this research has involved an analysis of over five years of
client data from an AOD residential treatment service designed to assess various
client factors that may predict treatment attrition.

The next stage of this research project is to discuss the research findings with
experienced AOD residential treatment clinicians. I wish to obtain clinical
perspectives about the findings, and where relevant discuss suggestions of
possible interventions designed to improve retention rates with relevant client
populations.

I am seeking to involve managers and/or clinicians from several AOD
residential treatment services and myself in a focus group that should last from
1 to 1.5 hours. The discussion will be audio-recorded and some notes taken but
no clinician or agency will be identified. Clinicians will have the right not to
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answer any questions or to leave the discussion group at any time if they so
wish. This research has been approved by the Edith Cowan University (ECU)
Research Ethics Committee. If you have any questions regarding the research
then do not hesitate to call me Mark Porter on (08) 9431 3781 and, 0404 844
227 (m), or either of my supervisors Associate Professor Lynne Cohen on 6304
5575 or l.cohen@ecu.edu.au or Dr. David Ryder on 6304 5254 or
david.ryder@ecu.edu.au.

If you are interested in speaking to someone

independent of this research, please contact the University Research Ethics
Officer, Ms. Kim Gifkins on Phone: (08) 6304 2170 or via email at:
research.ethics@ecu.edu.au.

I would appreciate your help in forwarding this letter to your Agency’s
residential treatment service clinical staff so interested clinicians may be able to
contact me and arrange a time and location to meet.

Yours sincerely,

Mark Porter

D. Psychology Candidate,

Lynne Cohen

Associate

Professor
School of Psychology,

School

of

Psychology
Edith Cowan University.
University.
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APPENDIX B

LETTER OF INTRODUCTION TO TC MANAGERS & CLINICIANS

Dear………,

My name is Mark Porter and I am undertaking a Doctor of Psychology degree
at Edith Cowan University. As part of my degree I am conducting a research
study designed to assess various client factors that may contribute to client
attrition from Alcohol and Other Drug (AOD) residential treatment services. As
you are aware treatment attrition from AOD residential services very often
predicts relapse to substance abuse. Early recognition of factors that predict
client attrition may allow residential treatment services to instigate interventions
designed to counter treatment attrition, and thus increase residential treatment
success rates.

The first stage of this research has involved an analysis of over six years of
client data from an AOD residential treatment service designed to assess various
client factors that may predict treatment attrition.

The next stage of this research project is to discuss the research findings with
experienced AOD residential treatment clinicians. I wish to obtain clinical
perspectives about the findings, and where relevant discuss suggestions of
possible interventions designed to improve retention rates with relevant client
populations.

I am seeking to involve clinicians from several AOD residential treatment
services and myself in a focus group that should last from 1 to 1.5 hours. The
discussion will be audio-recorded and some notes taken but no clinician or
agency will be identified. Clinicians will have the right not to answer any
questions or to leave the discussion group at any time if they so wish. This
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research has been approved by the Edith Cowan University (ECU) Research
Ethics Committee. If you have any questions regarding the research then do not
hesitate to call me Mark Porter on 0404 844 227 (mobile), or either of my
supervisors Associate Professor Lynne Cohen on Phone: 6304 5575 or
l.cohen@ecu.edu.au; or Dr. David Ryder on Phone: 6304 5254 or
david.ryder@ecu.edu.au.

If you are interested in speaking to someone

independent of this research, please contact contact the University Research
Ethics Officer, Ms. Kim Gifkins on Phone: (08) 6304 2170 or via email at:
research.ethics@ecu.edu.au.

I appreciate your interest in being involved with this research and encourage
you to contact me as soon as possible so I can arrange a suitable time and
convenient location for all participants to meet.

Yours sincerely,

Mark Porter

D. Psychology Candidate,

Lynne Cohen

Associate

Professor
School of Psychology,

School

of

Psychology
Edith Cowan University.
University.
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APPENDIX C

DESCRIPTION OF FOCUS GROUP FORMAT AND QUESTIONS

INTRODUCTION:

Participants will be informed that all their comments are confidential and
should not be repeated outside of the group. Participants will be informed that
the session will be audio-taped and notes taken to aid in later transcription of the
session to electronic form, but reassured that all comments will not be
identifiable. If any identifying names are mentioned during the recording, they
will be erased immediately. Pseudonyms will be used and transcripts will be
numerically coded.

The focus group will begin with a brief introduction about the success of AOD
residential treatment, but note that previous research findings have almost
always stressed that successful long-term treatment for substance abuse is
predicted by the amount of time in treatment. Treatment retention is therefore
the most critical factor in determining the long-term outcome of substance abuse
residential treatment. The research findings from the first stage of this research
that involved an analysis of archived client data from an AOD residential
service will be discussed with the group.

DISCUSSION OF CURRENT RESEARCH FINDINGS:

The group will be encouraged to express their thoughts on the research
findings in view of their own experiences of treatment attrition of specific
populations within their respective treatment services.
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PROPOSED SOLUTIONS TO PROMOTE CLIENT RETENTION:

The participants will be encouraged to suggest ideas that may improve
retention generally within residential services, and specifically to identify and
improve retention of identified populations at risk of attrition.

BARRIERS TO IMPROVED RETENTION:

Common ideas that emerge about how to improve treatment retention will be
discussed, especially with respect to possible barriers to successful introduction
in various treatment services.

QUESTIONS AND DE-BRIEF:

Any questions about the research will be answered and participants will be
reminded that all responses will remain confidential, and that all notes and the
recording of the session will be destroyed after transcription.

Mark Porter

D. Psychology Candidate,

Lynne Cohen

Associate

Professor
School of Psychology,

School

of

Psychology
Edith Cowan University.
University.
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APPENDIX D
Palmerston Association permission for use of archived data
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